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Mechanical conditioning has been shown to promote tissue formation in a wide 
variety of tissue engineering efforts. However the underlying mechanisms by 
which external mechanical stimuli regulate cells and tissues are not known.  This 
is particularly relevant in the area of heart valve tissue engineering (HVTE) owing 
to the intense hemodynamic environments that surround native valves. Some 
studies suggest that oscillatory shear stress (OSS) caused by steady flow and 
scaffold flexure play a critical role in engineered tissue formation derived from 
bone marrow derived stem cells (BMSCs). In addition, scaffold flexure may 
enhance nutrient (e.g. oxygen, glucose) transport. In this study, we 
computationally quantified the i) magnitude of fluid-induced shear stresses; ii) the 
extent of temporal fluid oscillations in the flow field using the oscillatory shear 
index (OSI) parameter, and iii) glucose and oxygen mass transport profiles. 
Noting that sample cyclic flexure induces a high degree of oscillatory shear 
stress (OSS), we incorporated moving boundary computational fluid dynamic 
simulations of samples housed within a bioreactor to consider the effects of: 1) 
no flow, no flexure (control group), 2) steady flow-alone, 3) cyclic flexure-alone 
and 4) combined steady flow and cyclic flexure environments. We also coupled a 
diffusion and convention mass transport equation to the simulated system.  We 
found that the coexistence of both OSS and appreciable shear stress 
magnitudes, described by the newly introduced parameter OSI-   ⃗⃗ ⃗⃗ , explained the 
high levels of engineered collagen previously observed from combining cyclic 
flexure and steady flow states. On the other hand, each of these metrics on its 
own showed no association. This finding suggests that cyclic flexure and steady 
flow synergistically promote engineered heart valve tissue production via OSS, 
so long as the oscillations are accompanied by a critical magnitude of shear 
stress. In addition, our simulations showed that mass transport of glucose and 
oxygen is enhanced by sample movement at low sample porosities, but did not 
play a role in highly porous scaffolds. Preliminary in-house in vitro experiments 
showed that cell proliferation and phenotype is enhanced in OSI-   ⃗⃗ ⃗⃗  
environments.  
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CHAPTER 1: INTRODUCTION 
  Heart valve disease is a major health care concern around the world. It is 
estimated that over 290,000 damaged heart valves are replaced with prosthetic 
valves annually, and it is expected to triple in the next four decades (Gandaglia et 
al., 2011). Native heart valves (NHVs) are multilayered highly adaptable and 
highly regulated structures. NHVs open and close nearly three billion times over 
the time course of the average human lifespan, and its motion is driven by 
surrounding hemodynamic forces (Schoen, 2008). NHVs are subjected to 
complex time-varying stresses due to combinations of flow, stretch and flexure 
(FSF), and their closing is aided by flow vortices behind the cusps on the arterial 
side (Schoen, 2008). NHVs are tightly regulated with continuous tissue 
remodeling activity capable of adapting to different hemodynamic loads 
(Kleinstreuer, 2006). 
The use of prosthetic heart valves substantially restores valve 
functionality. However, mechanical heart valves (MHVs) may result in hemolysis 
and possible platelet activation due to abnormal hemodynamics (Ratner et al., ).  
Similarly, biological heart valves (BHVs) can fail due to calcification and immune 
rejection (Kleinstreuer, 2006; Silverthorn, 2005). Other emerging techniques such 
as polymeric substitutes need to be further evaluated. Heart valve tissue 
engineering aims at the development of an in vitro implant with similar 
mechanical properties and anatomy as native valves. Moreover, a primary goal 
of this approach is to promote engineered tissue remodeling and growth 
(Ramaswamy et al., 2008). However, no long term/ perpetual reliable engineered 
  
 
2 
 
valve has been obtained thus far due to the complexity in mimicking the 
environments that native valves are exposed to (El-Hamamsy et al., 2010; 
Gandaglia et al., 2011; Sutherland et al., 2005). The use of computational fluid 
dynamics (CFD) has provided with insights on these complex time varying flow 
environments that NHVs are exposed to, but complete and exhaustive data from 
dynamic simulations are still needed today as well as simulation data correlation 
to experimental findings. The objectives of this proposal are to study the effects 
of valve-like movement on resulting fluid-induced stresses and mass transport 
efficiency (Oxygen and glucose) in developing engineered heart valve tissues. 
Our underlying hypothesis is that specimen movement effects will result in 
heighted, fluid-induced, oscillatory shear stresses on the specimens as well as 
an enhancement in the mass transport of key gas and nutrient species to the 
developing heart valve tissues. We will test this hypothesis by carrying out the 
following specific aims: 
2      Specific Aims 
Aim 1: Identify fluid-induced shear stress, velocity, and oscillatory 
stress distributions on engineered tissue specimens during valve-like 
deformations. 
Valve-like movement introduces spatial and time varying effects that may be 
important for the development of tissue engineered heart valve (TEHV) 
constructs.  We will perform specimen dynamic and static   steady   state CFD 
simulations, and we will evaluate the flow physics surrounding the constructs.  
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Aim 2: Quantify oxygen and glucose concentration profiles on 
engineered tissue specimen geometry during valve-like deformations. 
Valve-like movement produces varying velocities and pressures around and 
within the sample. This may aid in the flux of nutrients (glucose and oxygen) 
through the walls and into the cells and tissue. With data from the dynamic 
simulations, we will determine if specimen movement improves mass transport 
of 1 gas (oxygen) and 1 nutrient species (glucose) through the constructs.  
Aim  3:  Co-relate findings derived from aims 1 and 2 to supporting 
experiments on engineered tissue formation under static and dynamic 
tissue culture states, specifically engineered collagen production by the 
scaffold-seeded, bone marrow derived, mesenchymal stem cells. 
Spatially and t ime  varying fluid-induced stresses and mass transport (Oxygen 
and glucose) effects may improve t issue  formation in  TEHV constructs but 
the underlying mechanisms yielding this improvement are not known.  To 
provide further insights on this process,  we wil l  compare t ransport  
phenomena-related data from the simulations (aims 1 and 2) with collagen 
assay experimental  data obtained from the literature. 
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CHAPTER 2: HEART VALVES ANATOMY, DISEASE AND PROSTHETIC 
DEVICES 
2.1 Heart Valves 
Healthy heart valves are essential for proper blood circulation. Their role is 
to ensure uni-directional blood flow in the circulation. They consist of different 
tissue layers and are capable of adapting and remodeling their tissue 
composition according to the hemodynamic environments surrounding them 
(Waterbolk et al., 2006; Westhoff-Bleck et al., 2011; Zilla et al., 2008). The mitral 
and tricuspid valves are located between the atria and ventricles while the 
pulmonary valve is found intersecting the right ventricle and the pulmonary 
artery. The aortic valve resides between the left ventricle and the aorta.  
When blood enters the heart through the vena cava into the right atrium, it 
creates an increase in intra-chamber pressure. When the right atrial pressure 
exceeds the pressure in the right ventricle, the tricuspid valve opens thereby 
allowing blood to flow into the right ventricle. Simultaneously, the mitral valve 
also opens and permits blood to flow from the left atrium into the left ventricle. 
When the right ventricular pressure exceeds the pressure of the pulmonary 
arteries, the pulmonary valve opens, allowing blood to flow towards the lungs 
permitting exchange of oxygen and carbon dioxide. Concurrently, the aortic valve 
allows oxygen-rich blood to flow to the aorta and towards systemic organs and 
tissues. It closes once the pressure in the aorta exceeds the ventricular pressure.  
Over the course of the average human lifespan, native heart valves 
(NHVs) open and close an estimated three billion times (Schoen, 2008). During 
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each heartbeat, they are subjected to different hemodynamic loads in the form of 
flow, stretch and flexure (Ramaswamy et al., 2010; Salinas et al., 2014a; Salinas 
et al., 2014b). In past decades, NHVs have been thought to be passive 
structures. However, recent studies have shown tremendous cell and tissue 
activity occurring on its surface and within its layered structure (Ramaswamy et 
al., 2010; Sacks et al., 2009a; Sacks et al., 2009b; Salinas et al., 2014a; Salinas 
et al., 2014b).   
2.2 Heart Valve Disease 
 For simplicity, we refer from this point forward to any aberrant condition 
caused by anomalous structures and/or disease manifestation on heart valves as 
heart valve disease (HVD).  HVD can be caused by immune disorders, trauma to 
the valve or surrounding tissues, hypertention, degenerative valve calcification, 
endocarditis, rheumatic fever and by congenital birth defects (Bernard, 2008; Dal 
Pan et al., 2005; Elkayam and Bitar, 2005; Frederick J., 2006; Iyengar et al., 
2004; Lorna, 2010; Mohammadi and Mequanint, 2011; Neuenschwander and P. 
Hoerstrup, 2004; Shahbudin H., 2010; Siu and Silversides, 2010; Talwar et al., 
2005; Waterbolk et al., 2006; Westhoff-Bleck et al., 2011). It can be diagnosed by 
listening to the opening and closing of the valves through a stethoscope for the 
identification of heart murmurs. Other methods of detection include 
echocardiography, electrocardiogram, chest X-ray, cardiac catheterization, stress 
testing, or magnetic resonance imaging (Elkayam and Bitar, 2005; Iyengar et al., 
2004; Lorna, 2010; Siu and Silversides, 2010; Talwar et al., 2005).   
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  Common symptoms of HVD include aortic valve regurgitation, wherein 
one or more of the three leaflets do not close properly, thereby causing blood to 
flow back through the valve into the left ventricle (Baig and Punjabi, 2008; 
Bernard, 2008; Dal Pan et al., 2005; Elkayam and Bitar, 2005). When 
regurgitation fractions are large, the left ventricle will overwork to pump more 
blood out of the heart, which may result in left ventricular hypertrophy and 
possibly heart failure, if left untreated.  Another condition, aortic valve stenosis is 
a state in which the valve leaflets become stiff or even fuse together resulting in 
narrowing of the aortic valve (Shahbudin H., 2010; Talwar et al., 2005; Waterbolk 
et al., 2006). This in turn causes a reduction in the valve orifice area which 
exhibits disturbances in the normal hemodynamics (Iyengar et al., 2004; Lorna, 
2010; Mohammadi and Mequanint, 2011; Siu and Silversides, 2010; Talwar et 
al., 2005; Waterbolk et al., 2006; Westhoff-Bleck et al., 2011).  Valve stenosis 
can be congenital or be caused later in life due to, for example, onset of 
calcification of leaflets.  Importantly, the workload on the left ventricle increases 
considerably which can result in serious complications, as mentioned previously.  
2.3 Valve Prosthetics and Substitutes 
2.3.1   Mechanical Valves 
Mechanical heart valves (MHV) are prosthetic devices made out of high 
strength, artificial materials such as titanium and pyrolytic carbon (Mohammadi 
and Mequanint, 2011; Shahbudin H., 2010; Sotiropoulos and Borazjani, 2009). 
The most common MHV designs include the ball and cage, tilting disk, and the 
bileaflet (Butcher et al., 2011; Gandaglia et al., 2011; Shahbudin H., 2010; Zilla et 
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al., 2008) mechanical heart valve. The bileaflet design (e.g. bileaflet valve from 
St. Jude Medical) is currently very popular because of its superior 
hemodynamics, such as the ability to exhibit low transvalvular pressure gradients 
(Lorna, 2010; Mohammadi and Mequanint, 2011; Shahbudin H., 2010).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Mechanical and Biological Heart valves. 
MHVs have shown to be reliable and long lasting. However, there are 
some serious limitations that tend to exclude several segments of the population 
affected by severe HVD.  One problem is a predisposition to hemolysis and 
platelet activation which can trigger thrombus nucleation that could potentially 
cause blood flow disturbances (Arcidiacono et al., 2005; David and Hsu, 1996a; 
David and Hsu, 1996b). Furthermore, blood clots could potentially separate from 
the valve surface and cause a stroke if the clot migrates to the vasculature in the 
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brain.  Anticoagulation therapy (e.g. heparin) is required for as long as the MHV 
is implanted. The use of MHVs are mainly suggested for adults and are not 
recommended for young children who are prone to injury, women who wish to 
have children, individuals who cannot tolerate anticoagulation medication (e.g. 
heparin) and other sub-population groups who are at risk for traumatic episodes 
of bleeding (Baig and Punjabi, 2008; Talwar et al., 2005).  
2.3.2   Bio-prosthetic Valves 
Bio-prosthetic valves (BPVs) are created by forming the native tissue 
found in animals (Neuenschwander and P. Hoerstrup, 2004; Sha, 2010) into a 
valve-shaped construct. Sources of animal tissue include the porcine aortic valve 
and the bovine pericardium (Neuenschwander and P. Hoerstrup, 2004; Zilla et 
al., 2008). BPVs offer superior hemodynamics over any mechanical valve 
including the bileaflet design. However, they are pre-disposed to leaflet 
calcification and early structural breakdown (Ramaswamy et al., 2010; Salinas et 
al., 2014a; Salinas et al., 2014b). 
Homografts, derived from human cadavers serve as allografts 
(Anastasiadis et al., 2004; Shahbudin H., 2010).  The first aortic valve 
replacement with a homograft occurred in 1962 by Ross (Ungerleider et al., 
2010). These substitutes do not pose a risk of coagulation problems thereby 
eliminating the need for anticoagulation therapies (Anastasiadis et al., 2004).  
Other advantages include an absence of hemolysis, very good hemodynamics, 
good implant integration, resistance to infection and a low trans-valvular pressure 
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(Anastasiadis et al., 2004; Shahbudin H., 2010). However homografts are also 
calcification prone and are very limited in supply. 
2.3.3   Autografts 
Valve autografts are valve implants wherein a pulmonary valve is 
dissected and secured in the aortic position to compensate for a malfunctioning 
aortic valve.  Meanwhile a homograft is implanted in the pulmonary artery to 
substitute for the native valve that is removed.  This process, clinically known as 
the Ross procedure has demonstrated extensive benefits (Athanasiou et al., 
2004; Brown et al., 2004; Gamez et al., 2011; Jaggers et al., 1998; Khwaja et al., 
2005; Pretorius et al., 2008; Rus et al., 2004; Sarioglu et al., 2003; Slater et al., 
2005; Stelzer, 2011; Ungerleider et al., 2010) such as: i) no necessity for lifelong 
coagulation therapy, ii) minimal risk of calcification, iii) durability, iv) minimal 
scaring, v) adequate hemodynamics, vi) growth potential and vii) a low risk of 
infections and tissue rejection.  However, the critical shortcomings (Brown et al., 
2004; Gamez et al., 2011; Jaggers et al., 1998; Khwaja et al., 2005; Pretorius et 
al., 2008; Rus et al., 2004; Sarioglu et al., 2003; Slater et al., 2005; Stelzer, 2011; 
Ungerleider et al., 2010) that restrict this approach are that it: i) requires a high 
level of technical skill from the surgeon, ii) data to support long-term outcomes is 
limited, iii) homograft in pulmonary circulation will likely require replacement over 
human lifetime, iv) it cannot be used in children with structural abnormalities on 
their pulmonary valve (due to Marfan syndrome, systemic lupus erythematosus 
and juvenile rheumatoid arthritis). 
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2.3.4   Emerging technologies 
2.3.4.1   Polymer valves 
Development of polymer heart valves were investigated several years 
ago. However, the main challenge presented at that time was material durability, 
and this caused an abandonment of these technologies (Ghanbari et al., 2009). 
Recently, this area of research has been revisited due to more advanced state of 
the art polymer manufacturing technologies and the development of stronger, 
biocompatible polymers and polymer composite materials (Di Martino et al., 
1997; Ghanbari et al., 2009; Kidane et al., 2009; Ramaswamy et al., 2013).  
There is also a need for developing valve substitutes that can be integrated with 
minimal invasive techniques, such as percutaneous valve technologies, which 
polymer valves are thought to be able to meet (Ramaswamy et al., 2012; 
Shahbudin H., 2010; Vyavahare et al., 1997).   
Polymeric implants can be produced in large quantities and in multiple 
sizes with low manufacturing cost.  The polymers of preference are highly 
biocompatible elastomers that can be formed to resemble valve-like structures 
and are able to mimic the deformation of native valve leaflets (Ghanbari et al., 
2009; Kidane et al., 2009). However much needs to be done in development to 
ensure that these types of valves are durable long-term and this remains a 
subject of on-going research. To date, no polymer valve implant has been 
approved by the FDA. A critical limitation of polymer valves even if thrombosis, 
calcification, lack of functionality and weak structural properties can be overcome 
is that they cannot account for somatic growth in children who have severe HVD; 
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in other words, the replacement valve cannot grow and remodel with the overall 
growth of the child.  This means that multiple surgical procedures will still be 
needed for the pediatric patient with severe congenital HVD.  
2.3.4.2   Tissue Engineered Heart Valves 
The purpose of heart valve tissue engineering is to obtain an in vitro graft 
with mechanical properties and anatomical-like structures similar to those of 
native valves as well as to accommodate somatic growth (Martinez et al., 2013; 
Ramaswamy et al., 2010; Salinas et al., 2014a; Salinas et al., 2014b).  This can 
be potentially achieved by seeding biomaterial scaffolds with autologous cells 
such as bone marrow derived stem cells (BMSCs) (Kadner et al., 2002; Leor et 
al., 2005; Perry et al., 2003; Ramaswamy et al., 2010; Salinas et al., 2014a; 
Salinas et al., 2014b) and subjecting them to mechanical conditioning paradigms 
until sufficient heart valve cells and tissue growth in vitro has been achieved 
(Ramaswamy et al., 2014). Suitable cell sources for tissue engineered heart 
valves (TEHVs) are primary endothelial (ECs) and smooth muscle cells (SMCs) 
from a vein that can be harvested without compromise to the vasculature (e.g. 
saphenous vein in the leg)  (Schmidt et al., 2010; Siepe et al., 2008) as well as 
progenitor cells sources such as periodontal ligament cells (PDLs) derived from 
wisdom teeth  (Huang et al., 2009).  Stem cells such as bone marrow derived 
stem cells (BMSCs) offer the advantage of being obtained in a much less 
invasive approach and are accessible whenever needed (Engelmayr et al., 2006; 
Ramaswamy et al., 2010).  
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Figure 2. Tissue Engineering Approach 
In terms of the scaffolding components, common biodegradable polymers 
such as polylactic acid (PLA), polyglycolic acid (PGA) and blends or co-polymers 
of these two materials, e.g., a 50:50 blend (by weight) of PGA:PLLA nonwoven 
fabric or poly( lactic-co-glycolic acid), PLGA, have been utilized for heart valve 
tissue engineering purposes because of their biocompatibility and biodegradable 
properties (Chen and Wu, 2005; Fong et al., 2006; Leor et al., 2005). However, 
as cell sources are being identified and as mechanical conditioning protocols are 
being optimized, it is also critical to at the same time tailor scaffold properties that 
will demonstrate resilience to cyclic tensile, bending and fluid-induced stress 
states, while still permitting adequate levels of opening and closing dynamics 
(Chen and Wu, 2005; Fong et al., 2006; Leor et al., 2005).  In this regard, 
scaffolds made of decellularized animal valves have been utilized (Lichtenberg et 
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al., 2006), but unfavorable interactions between the colonizing cells and tissue 
proteins such as collagen have persisted (Gandaglia et al., 2011; Kleinstreuer, 
2006).  Recent work has also focused on the idea of using elastomeric 
substrates that can recapitulate native valve deformation (Ramaswamy et al., 
2010; Salinas et al., 2014a; Salinas et al., 2014b). Many challenges need to yet 
be overcome in optimizing in vitro grown TEHVs that are capable of withstanding 
in vivo hemodynamic environments and concomitantly permitting growth and 
tissue remodeling. These technical barriers need to be addressed in order to 
bring TEHVs from its current research state to that of clinical reality (El-Hamamsy 
et al., 2010; Gandaglia et al., 2011; Sutherland et al., 2005).  
 
CHAPTER 3: COMPUTATIONAL FLUID DYNAMICS AND ITS APPLICATIONS 
IN HEART VALVE STUDIES 
Heart valves are subjected to a complex hemodynamic environment.  The 
loading states on native valves during healthy, diseased, pre and post-surgical 
interventional states as well as prosthetic valves and emerging technologies (e.g. 
tissue engineered heart valves) can be delineated using computational predictive 
models.  In turn, several insights on how these results may translate to long term 
functionality can be made.  In this context, computational fluid dynamic (CFD) 
and finite element (FE) model development in the heart valve arena remain a 
vibrant area of research.  FE models are generally applied to evaluate solid 
surface strains due to cyclical stretching and bending.  On the other hand, CFD 
models examine the effects of fluid induced stresses on the leaflet surfaces.  In 
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this chapter we focus on CFD models.  However we also present fluid structure 
interaction approaches (FSI) which essentially combines both CFD and FE 
approaches to delineate both the fluid and solid mechanical responses of the 
leaflets.   
CFD processes for heart valve analyses are based on two numerical 
methods: The finite element method (FEM) and finite volume method (FVM) 
(Krause, 1985; Peskin, 1972; Peskin and McQueen, 1980). Both of these 
techniques subdivide the flow domain into a large number of finite entities, 
elements, in the case of the FEM, and control volumes, in the case of FVM 
(Krause, 1985; Peskin, 1972; Peskin and McQueen, 1980). Later, an iterative 
method is used to obtain the solution for each spatial element or volume. The 
overall goal is to solve the governing equations of the fluid given by the 3-
dimensional (3-D) Navier-Stokes equations, by simplifying large complex partial 
differential equations for the flow physics into algebraic equations (Hose et al., 
2006; Onate et al., 2004; Storti et al., 2008). Through this approach, CFD can 
numerically predict a solution for the nonlinear Navier-Stokes equations which 
allows the uncovering of the blood flow field surrounding a heart valve (Chandran 
et al., 2007; Kleinstreuer, 2006).  
The usage of CFD to study heart valves can be traced back to the early 
1970s. The first models accounted only for 2-dimensional (2D) analysis with 
oversimplified geometries. 3D models were constructed several years later in the 
late 1980s and early 1990s.  We summarize some important milestones in CFD 
of heart valves and heart valve prostheses here: The flow through a tilting disk in 
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a permanently half open position was simulated using a FEM approach by Shim 
and Cham (Shim and Chang, 1994).  Ge et al. (Ge et al., 2005; Ge et al., 2003) 
performed computer simulations for mechanical valves at Reynolds numbers 
(Re) describing laminar and turbulent flow; specifically at Reynolds numbers of 
750 and 6,000 respectively. The leaflets of this simplified valve were fixed at a 
completely open state.  McQueen et al. (McQueen and Peskin, 1985) described 
how computer modeling can be used to study design criteria in bileaflet valves 
with flat and curved leaflets.  Lei et al. (Lei et al., 1992) developed a 2D flow 
model around a Björk-Shiley tilting disk valve under steady state conditions. 
Simultaneously, Lei et al.  (Lei et al., 1992) conducted laser Doppler anemometry 
(LDA) on a experimental Björk-Shiley tilting disk valve setup that used a mixture 
of oil and kerosene as the fluid. However, helical vortices observed in the 
experimental data could not be predicted through the computational results. 
Kiris et al. (Kiris et al., 1997) focused on flow past a tilting disk in a fixed 
position of 30 degrees while ranging Re between two and six thousand. This 
study used a FVM and solved the 3D Reynolds-averaged Navier-Stokes (RANS) 
equations that also accounted for turbulence. King et al. (King et al., 1996) 
described the presence of orifice jets during systole velocities in a CarboMedics® 
valve. The jet regions were observed to merge towards the aortic walls, and 
there was evidence of jets in the central flow downstream of the valve leaflets. 
Experimental results from this study by means of flow visualization and LDA 
reasonably supported these observations. 
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King et al. (King et al., 1997) used a commercially available FEM based 
software called FIDAP (Fluent, Lebanon, NH) to simulate a simplified one-quarter 
model of a fixed valve at a Re = 1500. Different leaflet opening angles were 
used, and it was shown that downstream flow became more centralized and 
maximum velocity and maximum shear rate increased as well. 
3.1   General CFD steps 
Presently, there are a wide variety of commercially available software 
packages such as CFX ® (Ansys, Canonsburg, PA), CFD-ACE ® (ESI Group, 
France), COMSOL® (Burlington, MA),  FLEX PDE® (Scientific Software Solutions 
Int, GR - Europe ), FLUENT ® (Ansys, Canonsburg, PA), etc. The operating 
stages of any of these software packages can be described in three basic steps: 
pre-processing, solving, and post-processing. The pre-processing stage deals 
with the construction of geometry; meshing parameters such as grid type and cell 
size; boundary conditions for all inlets, outlets, walls and interfaces, coupling of 
equations, and incorporation of physical, mechanical and chemical properties (if 
needed)  into the system.  The solving stage involves the setting up of the 
numerical model, selection of the right solver, and monitoring the computed 
solution. The post processing stage mainly deals with the creation of 2-D and 3-D 
plots as well as videos in order to present and interpret the results. If general, 
revisions and updates to the model will need to be done if the results are 
erroneous due to lack of numerical accuracy. As a result, a large part of the 
modeling process will require validation of the computational results with a 
corresponding experiment.   
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3.2   Moving Boundary Problems 
Presently, simulations involving moving interfaces between flowing or 
deforming media are some of the most challenging problems in computational 
science (Driessen et al., 2007; Nobili et al., 2008; Vierendeels et al., 2008).  In 
the body, the movement of heart valves represents an active, dynamic system 
(Gilmanov and Sotiropoulos, 2005; Peskin, 1972).  From a modeling perspective 
the challenges are linked directly to the numerous differential equations that need 
to be satisfied for different components within the system (e.g. blood, vessel wall, 
moving leaflets, etc.), and that these solutions need to also be satisfied through 
mathematical relationships and appropriate boundary conditions that must hold 
at the interface of two components (Hong et al., 2009; Sotiropoulos and 
Borazjani, 2009; Vierendeels et al., 2008).  As the name implies, moving 
boundary methods elude to techniques that incorporate the movement of a solid 
component with the movement of the fluid in evaluating the fluid and in some 
cases, the solid stresses as well, as a function of the motion of the solid. In 
particular, FSI techniques comprise of scenarios where the movement of the 
solid-liquid interface is unknown in advance and must be determined as part of 
the solution. However to date, the ability to solve FSI problems accurately is 
limited largely to idealized cases, is not straight forward and is computationally 
expensive. As FSI techniques in heart valve research are generally time-
consuming, during the study planning stage, their usage has to be weighed 
against the added amount of accuracy that will be provided and level of 
additional insights that can be gained  to benefit the clinical problem at hand. 
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Initial algorithmic methods included the Eulerian and Lagrangian 
approach. In the Eularian case, the velocity field is provided for a fixed control 
volume. The generated grid is fixed and therefore has a grid velocity, 0gV . It 
is suitable for scenarios with small displacement and conversely is not suitable 
for systems with massive boundary movement such as those that occur in valve 
leaflets (Kukreja et al., 2008; Oshima et al., 2001; Sacks et al., 2009b). 
In the Lagrangian method The generated grid can move and therefore has a grid 
velocity equal to the velocity of the fluid, fg VV  . It is suitable when the 
system can be easily identified (e.g. elastic solid) (Nguyen and Lim, 2007), but it 
is not appropriate for systems with randomized boundary movement as it cannot 
treat arbitrary motion which can occur for example in heart valve disease states 
(e.g. severe mitral valve prolapse) (Oshima et al., 2001; Sacks et al., 2009b). 
Two moving boundary algorithms used for modeling of flow in deforming 
heart valves include the arbitrary Lagrangian-Eulerian (ALE) formulation and the 
immersed body method (IBM). The ALE formulation can be used to solve 
problems by incorporating the  velocity of the mesh or grid Vg and coupling it to 
the velocity of the fluid Vf.  Although the ALE approach has been extensively 
used, it presents the disadvantage that the mesh needs to be continuously 
deformed and updated as the control volume travels through the complete 
system. Given this fact, using the ALE approach could result in a large 
computational expense, especially for 3D FSI problems.  The ALE method is 
most suitable when the definition of a fixed control volume is not sufficient, e.g. 
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when dealing with large- displacement moving walls and in some cases, when 
the grid velocity can be accurately prescribed a priori (e.g. from patient specific 
medical images) (Sotiropoulos and Borazjani, 2009). 
On the other hand, the IBM allows for accurate interpolations at the fluid-
structure interface. This method is efficient as it requires lesser to no mesh 
update. It is flexible and it can be extended to multi-phase flows which makes it 
suitable for various applications (Kim and Choi, 2006; Zhang and Gay, 2007).  
Here, the entire fluid computational domain is discretized as an independent 
mesh. Similarly, the solid computational domain is also discretized as an 
independent mesh that is immersed inside the fluid domain.  Although both 
domains are independently meshed, their governing equations are coupled by 
adding body forces to the Navier-Stokes equations that describe the fluid domain 
(Gilmanov and Sotiropoulos, 2005; Kim and Choi, 2006; lmanov and 
Sotiropoulos, 2005; Tai et al., 2007; Zhang and Gay, 2007). This creates a no-
slip boundary effect at the boundary between the fluid and the solid, and the 
system accounts for these body forces at the start of the simulation until all 
iterations have been run. In view of the fact that the grid used to discretize the 
fluid domain is independent and does not have to be deformed or updated, the 
IBM is mostly appropriate for moving boundary problems  where the mesh 
displacements are not known beforehand, but rather has to be resolved during 
the simulation.  
Hong  et al. (Hong et al., 2009)  developed a FSI model using the 
FLUENT commercial CFD package to create a moving-grid with re-meshing 
  
 
20 
 
techniques based on the ALE approach. They wanted to observe the physical 
interactions of mechanical heart valves to investigate flows interacting with the 
moving leaflets. Different rotating positions and tilting angles of the bi-leaflet 
valves were considered.  It was shown that the valve rotation had a significant 
effect on the transvalvular pressure drop and that valve tilting greatly affects the 
flow direction.  
Ge and Sotiropolus (Ge et al., 2003) were the first to successfully use 
direct numerical simulations of pulsatile flow through bileaftet mechanical heart 
valves (BHMV). They simulated blood flow through a BHMV embedded within a 
straight aortic segment using an IBM approach, and they conducted in vitro 
studies using a similar experimental set-up. Specifically, they discretized the 
computational fluid domain with a curvilinear mesh, and the immersed bodies 
inside the mesh were treated as sharp-interface boundaries which were 
subsequently discretized using an unstructured meshing scheme. The IBM-
based model was able to closely match flow data from in vitro laboratory tests.  
Sotiropolus,  et al. (Sotiropoulos and Borazjani, 2009) also used the IBM to 
perform high-resolution FSI simulations of a physiologic pulsatile flow through a 
bi-leaflet mechanical heart valve (BMHV) in an anatomically realistic aorta and 
through an identical BMHV implanted in a straight aorta. The 3D aortic 
geometries were re-constructed from stacks of magnetic resonance imaging 
(MRI) 2D images. The comparisons showed that although some of the salient 
features of the flow remained the same, the specific geometry of the aorta (e.g. 
from patient to patient) could have a major effect on both the flow patterns and 
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the motion of the valve leaflets.  It was also shown that higher leaflet shear 
stresses were observed in the anatomical-like aorta rather than in the straight 
idealized case.  
When the valve material is flexible, there is higher complexity in CFD 
simulations and therefore it becomes more challenging because the deformation 
is localized and motions of the leaflets are highly spatially varying. This is the 
case in the computational modeling of polymer tissue engineered valves. In 
1972, Peskin et al. (Peskin, 1972) developed the first successful 2-D model of a 
simplified mechanical heart valve inside an artery in order to capture the 
movement of two solid leaflets embedded in a fluid domain. This was achieved 
by using an IBM approach. Peskin et al. continued to work on improving this 
method based on a finite difference scheme and later  demonstrated its suitability 
in capturing interactions between deforming bodies in fluids (Peskin, 1972; 
Peskin and McQueen, 1980).   
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Method Advantages Disadvantages 
Eulerian • Good for fixed system 
analysis with low/none 
boundary movement  
• Computationally 
feasible  
• Function of space only  
• Bad for large 
deformations 
• No adaptive mesh 
refinement 
Lagrangian • Neglects convective 
terms 
• Easy to solve  
• Computationally 
feasible 
•  Function of time only 
• Bad for large 
deformations  
•  No adaptive mesh 
refinement 
ALE • Adaptive mesh( f(x) or 
f(t) ) 
• Good for FSI with low 
boundary movement 
• adaptive mesh 
refinement if needed 
• Frequent Mesh 
conformation  
• Takes long time 
• Expensive for large 3D 
systems  
• Computationally 
challenging 
Immersed 
Body 
• Versatile 
• Adequate for large   
structural displacement 
• adaptive mesh 
refinement  
• Requires deep 
understanding of CFD 
•  Computationally 
challenging 
Table 1: Summary of the advantages and disadvantages of different CFD 
methodologies for moving boundary problems. 
 
3.3   Computer Simulations of mass transport  
In order for proper functioning and survival of cells and tissue, there must 
be an abundant supply of oxygen and nutrients. To our knowledge, there are no 
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studies conducted on the mass transport environments in TEHV constructs. 
However, extensive mass transport studies have been performed in other 
cardiovascular tissues such as arteries. Therefore, we have investigated the 
different mass transport models used in arteries with the aim of finding a robust 
mass transport model that can be used to study mass transport phenomena 
happening around TEHV constructs.  Arteries and other cardiovascular 
structures such as heart valves obtain oxygen and glucose by mass transfer 
between the tissue wall and flowing blood.  Mass transfer occurs via by 
convective mass transport and diffusive processes (Stangeby and Ethier, 2002; 
Yang and Vafai, 2006). The first is associated with pressure-driven transmural 
flow while the latter is initiated by species-specific concentration gradients (Ai 
and Vafai, 2006; Ethier and Moore, 1997). These gradients are caused by 
metabolic uptake and production of proteins by the cells embedded within 
tissues. 
  Mass transport through the arteries has been studied using various 
experimental, analytical, and computational methods. Extensive experimental 
investigations related to the mass transfer through the arterial wall have been 
pursued (Chung and Vafai, 2013; de Monte et al., 2013; Denny and Walsh, ; 
Prosi et al., 2005; Yang and Vafai, 2006; Yang and Vafai, 2008). Prosi et al.  
(Prosi et al., 2005) have classified these models as three major types, i.e. wall-
free, homogenous-wall, and multi-layer-wall models. The simplest models are 
named wall-free models. This model solves for the blood flow in the lumen while 
accounting for the effects of the arterial wall simply by means of an appropriate 
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set of boundary conditions. As such, the solution is independent of the mass 
transport processes inside the arterial wall. The values of boundary conditions, 
for instance the filtration velocity, are usually taken directly from the literature. 
Because of their simplicity, the wall-free models need a relatively small number 
of parameters, i.e. the diffusivity in plasma, the overall mass transfer coefficient 
of the wall with respect to the considered solute and the filtration velocity. 
Nonetheless, they cannot provide any information on the concentration profiles 
within the wall. This model has been used for the study of the dynamics of 
different solutes such as oxygen, albumin, and low-density lipoprotein (LDL) 
(Lantz and Karlsson, 2012; Yang and Vafai, 2006; Yang and Vafai, 2008).  
  The Second type of the mass transfer models are the homogeneous- wall 
models. In these models, the arterial wall is present; however, its complex 
heterogeneous structure is approximated by a simple homogeneous layer. The 
properties of wall are usually approximate values based on the assumption that 
the arterial wall is a homogeneous porous medium. Such models represent a 
reasonable compromise between the complexity of the input data and the 
accuracy of the results and are functional in cases where the concentration 
distribution across the arterial wall is not of primary importance. In addition to the 
study of hemodynamics and its localizing role, the homogenous-wall model can 
be used as a tool to investigate the interaction between the hemodynamical 
parameters and the arterial wall, for instance shear-dependent permeability of 
the endothelium. Homogeneous-wall models have been used by Ethier and 
Moore (Ethier and Moore, 1997) to study the concentration of oxygen and LDL 
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within the arterial walls. Stangeby and Ethier (Stangeby and Ethier, 2002) 
modeled the fluid flow within both the lumen and wall of a constricted and 
axisymmetrically stenosed artery and utilized the resulting flow pattern to study 
LDL transport from blood to the arterial wall. They coupled luminal blood flow and 
transmural fluid flow through the solution of Brinkman’s model. They prescribed a 
constant pressure at the adventitial vasa vasorum. In addition, they allowed 
variations in wall permeability due to the occurrence of plaque. 
To date, the most comprehensive model used to characterize the arterial 
wall is the multi-layer model (Ai and Vafai, 2006; Karner and Perktold, 2000). 
This model represents the arterial wall to be composed of several heterogeneous 
porous layers, i.e. endothelium, intima, and media. The multi-layer model is 
advantageous over the homogeneous-wall model in that it accounts for the 
particular characteristics and properties of each porous layer. However, it 
requires a large number of parameters to characterize the transport properties of 
each layer.  
3.3.1   Overview of governing equations in CFD 
3.3.1.1   Vector Operators  
Using a Cartesian coordinate system with i, j, and k unit vectors   can be defined 
as,    *
 
  
 
 
  
 
 
  
+ Eq. 1 
Gradient  
This can be used to define the gradient of a scalar function φ (x,y,z) which results 
in: 
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  Eq. 2 
The gradient is a generalized derivative that acts over multiple variables of a 
function.  
Divergence   
For a vector function U (x,y,z) where,  
  [
  
  
  
] Eq. 3 
The divergence of U can then be defined as: 
    
   
  
 
   
  
 
   
  
  Eq. 4 
The divergence of a vector field describes the flux at a point and therefore allows 
an inference of source or sink characteristic of the field.  
Dyadic Operator   
The dyadic operator (tensor product) of two vectors, U and V, is defined as:  
    [
            
            
            
] Eq. 5 
Using specific tensor notation the vectors can be combined into a single equation 
which shows as: 
  (    )  
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(     )  
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(     )
 
  
(     )  
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 Eq. 6 
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This allows the equations in each dimension to be written into a single equation. 
The tensor product is an expression of two vectors over a field that is analogous 
to the product of two scalar values.  
Matrix Transposition  
The operator T is used to denote the transpose of a matrix. So if a matrix defined 
as: 
   
[
 
 
 
 
  
  
  
  
  
  ]
 
 
 
 
 Eq. 7 
Then the transposed matrix is: 
[  ]  *
  
  
  
  
  
  
+ Eq. 8 
The Identity Matrix  
The identity matrix (also called the Kronecker Delta function) is defined by: 
  [
   
   
   
] Eq. 9 
3.3.1.2   Governing Equations  
Transport Equations 
The instantaneous equations of mass, momentum, and energy conservation will 
be discussed. For turbulent flows an average of the instantaneous equations is 
used.  
The Continuity Equation (Mass) 
The continuity equation is stated as:  
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   (  )    Eq. 10 
𝜌 is the fluid density, t is time, and U is the fluid velocity vector. The equation 
states that the amount of mass entering a system is equal to the amount of mass 
leaving the system.  
The Momentum Equations 
The momentum equation is defined as,  
 (  )
  
   (    )             Eq. 11 
Where the stress tensor τ is related to the strain rate as follows: 
   (   (  )  
 
 
    ) Eq. 12 
 U represents the fluid velocity vector, 𝜌 is the fluid density, p is the pressure, τ is 
the stress tensor and SM is the sum of other forces moving through the system.  
This equation is referred to as the Navier-Stokes equation and is used to 
describe the velocity of a fluid at a given space and time. It relates the movement 
of fluid across a system on the left side of the equation with the pressure, 
viscous, and other forces acting on that system on the left side of the equation. 
The Total Energy Equation 
The total energy equation is defined as: 
 (     )
  
 
  
  
   (      )    (   )    (   )           Eq. 13 
htot is the total enthalpy which can be related to the static enthalpy h(T,p) by,  
       
 
 
   Eq. 14 
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This form of the equation is written in terms of enthalpy. However there are many 
other forms that it can be take. Generally,  (   ) the work due to viscous stress 
is negligible because internal heating by the viscosity of the fluid is negligible. 
The term      is also neglected this is done to conserve momentum. Thus 
removing the neglected terms it can be rewritten as:  
 (     )
  
 
  
  
   (      )    (   )      Eq. 15 
The left side of the equation represents the work done by the movement of fluid. 
On the right side the first term represents energy change as a function of 
temperature T and the second term is a source that represents other potential 
sources of energy. The second term potentially could be zero.  
The Thermal Energy Equation  
The thermal energy equation is an alternative form of the total energy equation 
that can be used with low-speed flows. To begin mechanical energy K is defined 
as,  
  
 
 
   Eq. 16 
Taking the dot product of this equation with the momentum equation yields:  
 (  )
  
   (   )          (   )       Eq. 17 
Which when subtracted from the total energy equation yields the thermal energy 
equation: 
 (  )
  
 
  
  
   (   )    (   )                 Eq. 18 
Two different assumptions based on the fluid can be used to simplify the 
equation to the following final form:  
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 (  )
  
   (   )    (   )           Eq. 19 
If the fluid in question is a liquid in which variable-density effects are negligible 
then h can be interpreted as internal energy, 
    
 
 
 
This allows the previous equation to be rewritten as  
 (  )
  
   (   )    (   )               Eq. 20 
Which is equivalent to the final form when e is interpreted as h and       is 
neglected  
If the fluid is a compressible gas with low Mach flow then 
  
  
 and      are 
neglected leading to the same final form. The thermal energy equation is useful 
for avoiding stability issues in the total energy equation. It cannot be used if 
proper acoustic behavior is required or in the case of high speed flow.  
Equations of State 
The transport equations must be augmented with constitutive equations of state 
for density and enthalpy in order for the equations to form a closed system.  In 
general the equations take the form: 
   (   ) Eq. 21 
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    Eq. 22 
     (   )  Eq. 23 
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Incompressible Equation of State 
This is the simplest case. Density is constant and cp at most a function of 
temperature. 
        Eq. 24 
        
  
 
 Eq. 25 
     ( ) 
Ideal Gas Equation of State  
For an ideal gas, density is calculated from the ideal gas law and cp can be at a 
function of temperature. 
  
     
   
 Eq. 26 
        Eq. 27 
     ( ) Eq. 28 
 Real Gas and Liquid Equations of State 
For real gases and liquids a slightly more complex approach is necessary when 
deriving equations of state. Cubic equations of state are the most convenient 
means for predicting real fluid behavior. Four versions are used in Ansys: the 
Standard Redlich Kwong, Aungier Redlich Kwong, Soave Redlich Kwong, and 
Peng Robinson.  
Redlich Kwong Models  
Redlich Kwong variants of the cubic equations of state take the form:  
  
  
     
 
 ( )
 (   )
 Eq. 29 
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v is the specific volume     ⁄  and a, b, and c are variable that vary from model 
to model. 
The Standard Redlich Kwong Model  
In the Standard Redlich Kwong Model c is set to zero and a is set to: 
    (
 
  
)
  
  Eq. 30 
Where 
 n is 0.5  
   
           
 
  
  Eq. 31 
  
          
  
  Eq. 32 
The Aungier Redlich Kwong Model  
The Aungier form differs by having a non-zero value for c in order to improve the 
value of isotherms near the critical point. The value of n also differs based on the 
pure substance. The parameter c takes the form of: 
  
   
   
  
  (    )
       Eq. 33 
The exponent n is replaced with a best fit polynomial in terms of the acentric 
factor ω.  
                          Eq. 34 
The Soave Redlich Kwong Model   
The Soave Redlich Kwong Model applies to non-polar compounds and improves 
upon the original by generalizing the attraction term to depend on the acentric 
factor. This accounts for the fact that molecules are non-spherical and a range of 
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vapor pressure data in the development of the temperature dependency of this 
parameter.  b takes the same form as the original and c as well is the same. a(T) 
however takes the form:  
 ( )    (   (  √
 
  
))
 
 Eq. 35 
Where  
a0 is just a from the standard model 
                       Eq. 36 
Peng Robinson Model  
The Peng Robinson Model takes a similar form as the Redlich Kwong Model but 
differs slightly and is defined as: 
  
  
   
 
 ( )
         
   Eq. 37 
Where  
        
   
  
 Eq. 38 
 ( )    (   (  √
 
  
))
 
 Eq. 39 
          
    
 
  
  Eq. 40 
                             Eq. 41 
General Equations of State  
Equations of state can be user defined in CFX such that they are the following 
functions 
   (   )  Eq. 42 
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     (   )  Eq. 43 
Noting that:  
  
  
|
 
    
  
  
|
 
 Eq. 44 
In which v=1/𝜌. Solving for enthalpy yields: 
        [   
  
  
|
 
]
 
   Eq. 45 
Noting that user defined expressions must be thermodynamically consistent 
requires that all the mathematical properties for exact differentials be satisfied. 
Therefore dz(x,y) is an exact differential defined as: 
  (   )          Eq. 46 
With,  
   
  
  
|
 
  Eq. 47 
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 Eq. 48 
Consistency requires that: 
  
  
|
 
 
  
  
|
 
  Eq. 49 
With this in mind, for a general equation of state to be consistent it must obey the 
following: 
   
  
 
 
  
(   
  
  
|
 
)  Eq. 50 
Note that it is only valid to specify a general equation of state in which density is 
a function of T alone.  
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Conjugate Heat Transfer 
It is possible to create a solid region in which the equations for heat 
transfer are solved but those for flow are not. This is known as conjugate heat 
transfer and the solid region is known as a solid domain. The conservation of 
energy equation can be used to describe the transfer of heat due to the motion of 
the solid, conduction, and volumetric heat sources: 
 (  )
  
   (    )    (   )    Eq. 51 
Where h is the enthalpy, ρ is the density, λ is the thermal conductivity of the solid, 
and SE is an optional volumetric heat source. US represents the solid velocity 
which accounts for the motion of the solid with respect to a reference frame.  
3.3.1.3   Multicomponent Flow 
Scalar Transport Equation 
For a multicomponent fluid the Governing equations are used to solve for the 
bulk fluid however additional equations must be solved in order to determine how 
each component of the fluid is transported within the bulk. Each component has 
an individual conservation of mass equation and after Reynolds-averaging the 
equation can be expressed in tensor notation as: 
   ̃
  
 
 (  ̃  ̃)
   
  
 
   
(  ( ̃    ̃ )       
 ̅̅ ̅̅ ̅̅ ̅̅ )     Eq. 52 
Where: 
 ̃  is the mass average density of the fluid component i in the mixture 
 ̃  ∑( ̃  ̃  )  ̅⁄  is the mass average velocity field 
 ̃   is the mass average velocity of fluid component i 
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  ( ̃    ̃ ) is the relative mass flux  
Si is the source term for component i which includes the effects of chemical 
reactions  
If all the terms in the expanded equation are summed over all the components 
then the result is simply the standard continuity equation:  
  ̅
  
 
 ( ̅ ̃ )
   
   Eq. 53 
This is because the reaction rates Si must sum to zero. 
The relative mass flux term accounts for differential motion of the individual 
components. Depending on how it is modeled it can describe the effects of 
concentration gradients, pressure gradients, external forces, or temperature 
gradients. The primary effect of motion among the individual components is the 
concentration gradient and modeling of this effect gives yields diffusion-like term 
given by: 
  ( ̃    ̃ )   
  
 ̅
  ̃ 
   
 Eq. 54 
The molecular diffusion coefficient, 𝛤i, is assumed to be equal to 𝜌Di where Di is 
the kinematic diffusivity. The mass fraction of component i is then defined as:  
 ̃  
 ̃ 
 ̅
  Eq. 55 
Plugging the previous two equations in to the conservation of mass equation 
yields: 
 ( ̅ ̃ )
  
 
 ( ̅ ̃  ̃ )
   
 
 
   
(  
  ̃ 
   
)  
 
   
(   
   
 ̅̅ ̅̅ ̅̅ ̅̅ ̅)      Eq. 56 
The turbulent scalar fluxes are modeled using the eddy dissipation assumption:  
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 ̅̅ ̅̅ ̅̅ ̅̅ ̅  
  
   
  ̃ 
   
 Eq. 57 
   is the turbulent Schmidt number. This can then be substituted into the 
equation and assuming that you have mass weighted averages of Yi the final 
equation is defined as: 
 ( ̅ ̃ )
  
 
 ( ̅ ̃  ̃ )
   
 
 
   
(     
  ̃ 
   
)     Eq. 58 
Where: 
         
  
   
  Eq. 59 
Constraint Equation for Components 
The CFX-solver solves NC-1 mass fraction equations for all but one component 
so the last component is known as the constraint component. The last mass 
fraction is determined by the equation: 
∑      
  
        Eq. 60 
Multicomponent Fluid Properties  
If there is a given volume V of fluid mixture then Mi is the mass of component i 
present in the volume;  ρi =Mi/V is then the density of that component; Vi is the 
partial volume of that component that would be taken up by that component of 
the same mass at the same local temperature and pressure as the mixture. The 
thermodynamic density of the component is an evaluation of the equation of state 
under the mixture temperature and pressure is expressed as〈  〉  
  
  
⁄ . Since 
all partial volumes must add up to the total volume, then: 
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  ∑
  
 
  
      ∑
  
〈  〉
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  ⁄
  
      ∑
  
〈  〉
  
      ∑
   
〈  〉
  
      Eq. 61 
Or: 
 
 
 ∑
  
〈  〉
  
      Eq. 62 
Thus the mixtures density can be calculated with knowledge of the mass 
fractions and thermodynamic density of each component.  
An arbitrary constitutive property may be calculated from: 
  ∑     
  
      Eq. 63 
Where α can be the laminar viscosity µ, the specific heat at constant volume cv, 
the specific heat at constant pressure cp, and the laminar thermal conductivity λ. 
Energy Equation  
Extending the conservation of energy equation to multicomponent fluids requires 
adding an additional diffusion term:  
 
   
[∑     
   
   
  
 ] Eq. 64 
For turbulent flows this term is Reynolds-averaged giving: 
 
   
[∑ ( ̃    
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 ( ̃    
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 ( ̃    
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]  Eq. 65 
Though this expression contains several fluctuating terms it is not possible with 
current models to account for these effects individually thus only the mean effect 
is retained in the calculations. Inserting this extra term into the energy equation 
yields the following equation: 
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 )     Eq. 66 
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Multicomponent Energy Diffusion  
In the special case that all diffusivities are the same and equal to thermal 
conductivity divided by specific heat capacity:  
     
 
  
 Eq. 67 
This holds when the Lewis number is unity for all components: Lei=λ/(cpΓi)=1  for 
turbulent flow assuming unity is usually just as good just as good as the common 
practice of using the unity Schmidt number. For Lei=1 the energy equation 
simplifies exactly to the following: 
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]     Eq. 68 
This equation has the advantage of having only a single diffusion term reducing 
the number of computations.  When component dependent turbulent Schmidt 
numbers are specified then turbulent energy flux must be specified. This can be 
achieved by splitting turbulent fluctuation of enthalpy into its contributions from 
temperature, pressure, and component mass fractions: 
      
  
  
  
   ∑    
 
 
  
    Eq. 69 
Using this transformation the turbulent energy flux can then be modeled using 
the eddy diffusivity model with turbulent Prandtl number for the temperature 
fluctuations plus the sum of the secondary enthalpy transport terms:  
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 Eq. 70 
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    Eq. 71 
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Inserting the eddy diffusivity model for turbulent component mass fluxes yields 
the following model for the turbulent enthalpy flux: 
       
̅̅ ̅̅ ̅̅ ̅̅    
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     Eq. 72 
Using these relations with the energy equation allows it to be rewritten for 
generalized turbulent component transport: 
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If the eddy diffusivity assumption is being used to model the turbulent mass flux 
for each component then the equation becomes: 
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]      Eq. 74 
3.3.1.4   Additional Variables  
Transport Equations for Additional Variables 
The general form of the transport equation for an additional variable is: 
 (  )
  
   (   )    (     )     Eq. 75 
Where: 
U is the fluid velocity in a fluid or porous domain or Us in the case of solid motion 
velocity with Us is the solid velocity 
𝜌 is the mixture density in mass per unit volume 
Φ is the conserved quantity per unit volume, or the concentration 
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φ=Φ/𝜌 is the conserved quantity per unit mass 
Sφ is a volumetric source term, with units of conserved quantity per unit time  
DΦ is the kinematic diffusivity for the scalar 
For turbulent flow, this equation is Reynolds-averaged and becomes: 
 (  )
  
   (   )    ((    
  
   
)  )       Eq. 76 
Where: 
Sct is the turbulence Schmidt number 
µt is the turbulence viscosity 
Diffusive Transport Equations for Additional Variables 
The general form of the diffusive transport equation for an additional variable 
(non-reacting scalar) is: 
 (  )
  
   (     )      Eq. 77 
The variables are all the same as in the regular transport equation. 
Poisson Equations for Additional Variables 
The general form of the Poisson equation for an additional variable (non-reacting 
scalar) is: 
  (     )       Eq. 78 
The variables are also the same as the past two equations.  
Momentum Sources 
A momentum source is implemented as a force per unit volume acting on the 
fluid(s). Momentum sources can be used to model isotropic losses in porous 
regions, directional losses in porous regions among other processes.  
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Isotropic Loss Model  
The momentum loss through an isotropic porous region can be formulated using 
permeability and loss coefficients as follows: 
      
 
     
        
 
 
      Eq. 79 
      
 
     
        
 
 
      Eq. 80 
      
 
     
        
 
 
      Eq. 81 
Where Kperm is the permeability coefficient and Kloss is the quadratic loss 
coefficient. The linear component of this source represents the viscous losses 
and the quadratic term represents inertial losses. Alternatively the source may be 
formulated using linear and quadratic resistance coefficients substituting CR1 and 
CR2 for the others as follows: 
    
 
     
  Eq. 82 
         
 
 
  Eq. 83 
3.3.1.5   Directional Loss Model  
The momentum source through an anisotropic porous region may be modeled 
using the directional loss model. With this model the streamwise direction must 
be specified. If the streamwise coordinate system was (x’,y’,z’) such that the x’-
axis is aligned with the streamwise direction and the y’ and z’ axes lie on the 
transverse plane then the momentum losses in these directions are: 
       
 
     
          
  
 
        Eq. 84 
       
 
     
          
  
 
        Eq. 85 
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        Eq. 86 
In this case there is an individual permeability and loss coefficient term for both 
the stream-wise and transverse directions. Just as in the isotropic model these 
may be expressed in terms of the linear and quadratic resistance coefficients. 
3.3.1.6   General Momentum Sources 
The general momentum source is available in the instance that there sources are 
not covered by the isotropic or directional loss models. A source for each 
direction is given by: 
              Eq. 87 
              Eq. 88 
               Eq. 89 
Where Sspec are the specific momentum components. Additionally a 
representative scalar linearization coefficient based on the derivate 
   ⃗⃗ ⃗⃗  ⃗
  ⃗⃗ 
  Eq. 90 
May be specified to provide robust convergence when a general momentum 
source is present. 
3.3.1.7   Immersed Solids 
An immersed solid is a rigid compact body capable of moving within a fluid 
domain. In order to capture the movement of the immersed body, the fluid 
volume is forced to move with the solid by applying a source term to the 
momentum equation.  
       (     
 )  
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       (     
 ) 
       (     
 ) 
Where              are the three components of fluid velocity. 
  
       
      
   are the components of forcing velocity due to the immersed solid. 
   is a large number, and is evaluated as the average of the three diagonal 
coefficients in the momentum equation.  
  is the Momentum Force Scaling Factor. 
3.4 CFD usage for emerging technologies in Heart Valve Research 
Driessen et al. (Driessen et al., 2007) employed a mathematical model to 
study the mechanical properties of a TEHV. Engelmayer et al. (Engelmayr et al., 
2008) utilized GAMBIT® (v2.1) and FLUENT ® (v6.2) ( Ansys, Canonsburg, PA) 
to study flow behavior through a novel bioreactor for heart valve tissue 
engineering. Computational studies on the flow physics on and around the 
housed bioreactor specimens (Engelmayr et al., 2008) were subsequently 
evaluated further by Ramaswamy et al. (Ramaswamy et al., 2010). The 
commercially available software FLUENT ® (Ansys, Canonsburg, PA) was 
employed on a structured grid composed of 1.43 million hexahedral elements 
and 1.54 million nodes.  They hypothesized that the oscillatory shear stresses 
that were created during specimen, valve-like bending were involved in 
engineered heart valve tissue formation (Ramaswamy et al., 2010).  
Ramaswamy et al. (Ramaswamy et al., 2014) also developed a u-shaped novel 
bioreactor. Its design permitted the in vitro recreation of physiologically relevant 
shear stress magnitudes.  
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Figure 3. Custom made mechanical conditioning bioreactor for HVTE studies 
(Engelmayr et al., 2006). Modes: Flow, stretch, flexure. 
 
 
Figure 4. Computational fluid dynamic simulations on native heart valve (a) and 
rectangular (b) Geometries (Ramaswamy et al., 2010).  
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3.5   Recent Advances in CFD Applications for Heart Valve Research 
3.5.1   Imaging to Meshing to CFD 
 Blood flow physics that occur in the neighborhood of native or prosthetic 
valves can be a key indicator of the functionality of the valve (Sotiropoulos and 
Borazjani, 2009). It can reveal disease in native valves (Ryan et al., 2006; 
Schlosshan et al., 2011) and performance issues in the case of prosthetic ones 
(Sotiropoulos and Borazjani, 2009).  In order to develop a strong-accurate CFD 
model, the incorporation of these flow physics as boundary or initial conditions is 
paramount (Le and Sotiropoulos, 2013; Wong et al., 2012). Equally important is 
the usage of geometry structures that correctly depict valve and surrounding 
tissues in vivo (Le and Sotiropoulos, 2013). This represents a key challenge due 
to the light scattering nature of blood which excludes the usage of some imaging 
techniques (Sengupta et al., 2012a). It is also important to be able to compare 
computational results with experimental data, and this can be achieved only if the 
valvular flow physics can be sufficiently captured in vivo. 
 Doppler echocardiography and cardiac magnetic resonance (CMR) have 
typically been used to obtain mainly unidirectional velocity profiles (2D) 
(Cavalcante et al., 2012; Sengupta et al., 2012a). More advanced versions such 
as the 4D flow CMR can provide temporal and 3D spatial information (Sengupta 
et al., 2012a) with resolution in the order of 50ms and 3mm3, respectively 
(Sengupta et al., 2012a).  Color Doppler echocardiography has been used to 
observe abnormal flow patterns and superimposed turbulence (Ryan et al., 2006; 
Schlosshan et al., 2011). It does so via application of an ultrasonic beam that can 
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be used to compute axial velocities (Leopaldi et al., 2012; Ryan et al., 2006). It 
can also provide radial velocities, but the integration of both radial and axial 
velocities, necessary for obtaining the true flow field, is not usually obtained in 
routine clinical management (Sengupta et al., 2012a).  
Particle image velocimetry (PIV) is a popular technique for the 
characterization of the flow field through heart valves and chambers (Sengupta et 
al., 2012b). It is capable of capturing a highly physiologically similar flow field by 
using tiny particles that light up in response to the presence of a laser light. PIV 
does not track the individual particle displacement; it tracks the alignments of the 
particles as a group (Lim et al., 1998).  Imaging technologies such as computer 
tomography (CT) scans, ultrasound and MRI can help in the virtual geometry 
reconstruction of cardiovascular component such as heart valves, chambers, and 
vessels (De Bartolo et al., 2012; Lantz and Karlsson, 2012; Le and Sotiropoulos, 
2013; Wong et al., 2012). For instance, CT consists of taking multiple 2D cross 
section images that can be later stacked together for 3D reconstruction 
(Sengupta et al., 2012b). Presently, the accuracy and acceptability of CFD 
models greatly rely on these types of imaging techniques, which are capable of 
acquiring extensive 2D data that can be later processed to reconstruct 3D 
structures (Le and Sotiropoulos, 2013).  
 The advancement in imaging technologies, computational capabilities, 
better understanding of electrophysiology of the heart and its interactions with 
neighboring tissues and organs have infused new hope for the development of a 
virtual model that can closely resemble that of the heart and its valves 
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(Cavalcante et al., 2012; De Bartolo et al., 2012; Le and Sotiropoulos, 2013). 
Meshing geometries with high density elements and nodes can be promptly 
accomplished through super computers (Haj-Ali et al., 2008; Kleinstreuer, 2006; 
Salinas et al., 2014a; Salinas et al., 2014b). Geometry re-meshing can be 
triggered by setting tolerance levels for specific parameters such as element 
volume or element angle deformation thereby delaying negative volume sectors 
which will cause computational errors that will terminate the iteration process 
without yielding any results (Ansys, 2014). Parallel processing with state of the 
art processors makes the iterative solution process more efficient. It is a common 
practice to set the number of iterations in the thousands. It also helps to achieve 
academic and research standard convergence criteria for continuity and 
momentum equations (Ramaswamy et al., 2010; Salinas et al., 2014a; Salinas et 
al., 2014b). We outline a few of the most up-to-date efforts in heart valve 
computational fluid modeling that were able to leverage accurate geometric 
reconstructions derived from original medical imaging datasets.  We include 
specific case studies where appropriate (labeled with a case number) when 
visual illustrations are also provided.  Case # 1:  Le and Sotiropoulos (Le and 
Sotiropoulos, 2013) employed the curvilinear immersed boundary method and 
developed a FSI model of a left ventricle and a mechanical heart valve. The 3D 
reconstruction of the ventricle geometry was obtained by merging 2D MRI 
images from a healthy individual. The results were found to be in good 
agreement with clinical observations.  This work revealed complex valve leaflet 
kinematics and emphasized the importance of patient specific simulations for 
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heart valve prosthesis and other cardiac devices. In Figure 5, it can be seen that 
there was the formation of coherent structures at different time points during the 
cardiac cycle. Coherent structures were well developed zones within the flow that 
exhibited a characteristic flow pattern such as vortices. Studying the formation 
and transient life of such structures could help in understanding damage to blood 
cells as well as prosthetic valve dynamics.   
 
Figure 5. The formation of coherent structures inside the left ventricular chamber 
during diastole in (a). The small scale structures are advected into the aorta 
during systole in (d). The red dot in the inset shows the time instance in the 
cardiac cycle. (From Le TB, Sotiropoulos F. Fluid-structure interaction of an 
aortic heart valve prosthesis driven by an animated anatomic left ventricle. J 
Comput Phys. 2013(244):41-62. With permission from Elsevier) 
 
Pellicioni et al. (Pelliccioni et al., 2007) utilized the Lattice-Boltzman (LB) 
method in a flow simulation past a mechanical valve in the aortic position. Other 
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efforts that have utilized the same approach include the work of Krafczyk et al.  
(Krafczyk et al., 1998; Krafczyk et al., 2001). These efforts showed that the LB 
method was capable of predicting blood flow physics accurately.   
Case # 2: Shahriari et al. (Shahriari et al., 2012) developed a model for a 
bi-leaflet mechanical valve flow study. The model employed a smoothed particle 
hydrodynamics approach which is a mesh free approach. This study was the first 
of its kind to use this technique in the area of heart valve research and was 
originally developed for the astrophysics arena. Essentially, the fluid is 
represented by interacting particles that obey the Navier-Stokes equation using 
an interpolation function. The particles can move freely in the reference frame 
with a Lagragian configuration. The trajectory of the particles was used to 
correlate flow patterns with damage to blood components. In addition, large 
recirculation regions were found to be present in the dysfunctional BMHVs as 
shown in Figure 6. 
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Figure 6. The patterns associated with accumulative shear stress applied on 
particles passing through: (a) a normal BMHV and (b) a dysfunctional 
BMHV.(From Shahriari S, Maleki H, Hassan I, Kadem L. Evaluation of shear 
stress accumulation on blood components in normal and dysfunctional bileaflet 
mechanical heart valves using smoothed particle hydrodynamics. J Biomech. 
2012;45(15):2637-2644. With permission from Elsevier) 
 
Case # 3: Borazjani(Borazjani, 2013) developed a three-dimensional FSI 
model for both mechanical and bio-prosthetic valves. He used a Fung model for 
the soft tissue and validated his results with experimental and numerical heart 
valve tissue data. The mechanical results were validated using flow 
measurements from a mechanical heart valve. Figure 7, 8 and 9 show the 
comparison of shear stress, structure formation and the non-dimensional second 
Piola–Kirchhoff stress. It can be seen that shear stress acting on blood 
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components was higher in the mechanical valve. Other efforts have shown a 
correlation between higher shear stress and thrombus nucleation(Banerjee, 
2013; De Bartolo et al., 2012). The non-dimensional second Piola-Kirchhoff 
stress was used to identify the points of maximum stress which found to occur 
when flow pushed the valve toward the open position. 
 
Figure 7. FSI simulations with peak Re = 6000: Comparison of instantaneous 
local maximum shear sloc contours over the midplane of the valve for an MHV 
vs. BHV implanted in a straight aorta at time t = (a) 52, (b) 93 , (c) 186, and (d) 
334 ms within the cardiac cycle. (From Borazjani I. Fluid–structure interaction, 
immersed boundary-finite element method simulations of bio-prosthetic heart 
valves. Comput Methods Appl Mech Eng. 2013;257(0):103-116. With permission 
from Elsevier) 
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Figure 8. FSI simulations with peak Re = 6000: 3D wake structure visualized by 
the iso-surfaces of q-criteria for a MHV vs. BHV implanted in a straight aorta at 
time t = (a) 52, (b) 93 , (c) 186, and (d) 334 ms within the cardiac cycle. (From 
Borazjani I. Fluid–structure interaction, immersed boundary-finite element 
method simulations of bio-prosthetic heart valves. Comput Methods Appl Mech 
Eng. 2013;257(0):103-116. With permission from Elsevier) 
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Figure 9. FSI simulations of BHV: The shape of the BHV and the magnitude of 
the non-dimensional second Piola–Kirchhoff stress S on the BHV at time instants 
t = (a) 52, (b) 93 , (c) 186, and (d) 334 ms within the cardiac cycle. (From 
Borazjani I. Fluid–structure interaction, immersed boundary-finite element 
method simulations of bio-prosthetic heart valves. Comput Methods Appl Mech 
Eng. 2013;257(0):103-116. With permission from Elsevier) 
 
 Case # 4: We performed computational simulations of flow in a custom 
made bioreactor (Ramaswamy et al., 2014) capable of imparting physiologically 
relevant shear stresses onto rectangular scaffolds (Figure 10). The rationale for 
replicating native valve flow physics on rectangular surfaces was previously 
documented (Ramaswamy et al., 2010).   
The movement of the samples was assumed to follow a parabolic profile 
during cyclic flexure deformation (Salinas et al., 2014a; Salinas et al., 2014b). In 
this study we wanted to observe the effect of flow pulsatility versus sample 
movement on oscillatory shear stresses (OSS).  OSS has been shown to be 
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important in the differentiation pathways of bone marrow derived stem cells 
(BMSCs) (Arnsdorf et al., 2009b; Arnsdorf et al., 2009a; Jacobs et al., 1998).  
Our interests were in BMSC differentiation to support the heart valve phenotype, 
as it is a popular cell choice utilized in heart valve tissue engineering studies.  
We performed a quasi-static analysis on steady flow simulations at different 
sample bending positions. Pulsatile simulations were performed for fixed sample 
positions as described in Salinas et al.(Salinas et al., 2014a; Salinas et al., 
2014b). All the simulations were carried out using CFX ® (Ansys, Canonsburg, 
PA) software with parameters described in Figure 11. 
 
Figure 10. (A) Peristaltic pump used to induce flow through the FSF bioreactor. 
(B) FSF bioreactor set up. (C) Single FSF bioreactor chamber. (D) Bioreactor 
fluid domain showing the position of the three rectangular specimens. 
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Figure 11: (a) U-shaped bioreactor showing the three samples. (b) Front view of 
the bioreactor inlet, outlet and sample position. The Table indicates the 
parameters for steady and pulsatile simulations. 
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Figure 12: OSI distribution along the centerline of samples for (a): Inner wall and 
(b) Outer wall.Notice how the OSI variability was lowest along the inner and outer 
walls of straight samples (N=3) subjected to pulsatile flow. The average OSI in 
the inner surface was found to be 0.2627, 0.2121, 0.2396, and 0.1009 for 
straight, semi-bent, fully-bent, and quasi-static, respectively. In that same order, 
the outer wall values were 0.2689, 0.1859, 0.2159 and 0.2485 (Salinas et al., 
2014a; Salinas et al., 2014b). 
 
An oscillatory shear index (He and Ku, 1996) was used to quantify the 
OSS along the center line of the specimens. OSI was overall found to be the 
most uniform along both walls (inner and outer) for straight specimens that 
underwent pulsatile flow (Figure 12). In addition, mean OSI distribution was 
highest along both the inner and outer walls when specimens (N=3) were held 
fixed in a straight configuration (average specimen OSI = 0.26, inner wall; 
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average specimen OSI = 0.27, outer wall). Thus, these types of analyses 
illustrate an example of deriving insights from computational efforts without 
building complex CFD models (e.g. FSI), in aiding the design of experiments. In 
this case, the models guided the planning of maximizing OSS levels in BMSC-
seeded scaffolds uniformly. Subsequent evaluation of OSS-induced 
mechanobiology, could thus be accomplished in a clear-cut fashion, purely 
through a physiological pulsatile waveform, without the need for moving the 
specimens (Salinas et al., 2014a; Salinas et al., 2014b). 
3.6   Conclusions and Future Outlook 
The advent of new technologies such as tissue engineered heart valves 
and percutaneously-deployed valves are areas that are still relatively 
understudied using CFD.  In this regard, several insights may be gained even 
from very straightforward modeling approaches (e.g. laminar flow, static models) 
provided that accurate depiction of the geometric features can be reproduced.  
On the other hand, the culmination of CFD research over the last several years 
has enabled streamlining of more advanced methodologies such as FSI-based 
approaches, to the extent that research groups that utilize their in-house 
developed code are able to simulate very complex dynamic states of heart valves 
in a highly efficient fashion.  While these approaches are also available in 
commercial CFD packages, direct control of localized deformation states is still 
tedious.  In the years to come, it is expected that these packages will begin to 
offer more flexibility in the prescription of mesh movement, thereby allowing for 
more direct control of the simulations by the end-user.   
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Irrespective of whether the usage of an advanced CFD techniques 
become commonplace, or if several insights on the flow physics can be 
uncovered in emerging heart valve therapeutics using CFD, we expect that the 
findings resulting from CFD simulations in the heart valve research area will now, 
perhaps more than ever before, play a central role in the research or clinical 
process.  This can be by way of, for example, enhancing the design features of a 
tissue engineered heart valve or a prosthetic valve, or alternatively, towards the 
evaluation of in vivo valve functionality, thereby guiding the surgeon in selecting 
the next course of treatment for the patient. 
 
CHAPTER 4: COMPUTER SIMULATIONS OF VALVE LIKE DEFORMATIONS 
4.1   Introduction 
Tissue engineered heart valves (TEHVs) could potentially serve as a 
viable solution to congenital valve disease among pediatric patients who 
currently have extremely limited options (Fong et al., 2006; Kadner et al., 2002; 
Martinez et al., 2013; Schmidt et al., 2006). The primary appeal of TEHVs lies in 
their potential to integrate and grow with the patient, but in addition, TEHVs could 
potentially overcome current valve replacement barriers such as hemolysis, 
immune rejection, calcification, anticoagulation therapies and the need for 
multiple invasive surgeries (Chen et al., 2013; Hmiel, 2012; Leong et al., 2013; 
Munnelly et al., 2012; Nora et al., 2012; Syedain, 2009a).  
As with native heart valves, the mechanical environment that TEHVs are 
exposed to will direct the nature of tissue remodeling that will occur. Studies have 
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examined the remodeling responses of TEHVs using a variety of cell sources, 
both in vivo as well as in vitro in heart valve bioreactors, i.e., devices that impart 
valve-relevant mechanical stimuli (some combination of cyclic flexure, flow and 
cyclic stretch) to developing tissues. Many bioreactor-based studies have 
associated higher cell activity and tissue formation with fluid induced shear 
stresses (Kadner et al., 2002; Karim et al., 2006). A landmark study conducted 
by Engelmayr et al. (Engelmayr et al., 2006) utilized a bioreactor to condition 
rectangular polyglycolic acid /poly L-lactic acid (PGA/PLLA) non-woven fibrous 
scaffolds seeded with bone marrow stem cells (BMSCs). They reported that the 
combination of cyclic flexure and steady flow (flex-flow) greatly augmented 
engineered collagen formation when compared to steady flow or cyclic flexure-
alone. Interestingly, studies elsewhere described that oscillatory flow conditions 
mechanically regulate BMSCs (Arnsdorf et al., 2009b; Arnsdorf et al., 2009a; Li 
et al., 2004; Vermot et al., 2009). Indeed, oscillatory shear stress (OSS) has 
been shown to mediate BMSC proliferation and differentiation, (Arnsdorf et al., 
2009b; Arnsdorf et al., 2009a). Specifically, Arnsdorf et al. (Arnsdorf et al., 
2009b; Arnsdorf et al., 2009a) reported that OSS has the potential to promote 
osteogenic differentiation of BMSCs by activating key molecular pathways; 
meanwhile, Li et al. (Li et al., 2004) reported an increase in BMSC proliferation in 
addition to increases in intracellular Ca2+ signaling. Particularly relevant to heart 
valves, OSS was also found to directly regulate the gene klf2a which is required 
for normal valve development (Vermot et al., 2009).  
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As a mechanical conditioning metric, steady flow on its own will serve to 
impart shear stresses, while cyclic flexure-alone will impart OSS on the surfaces 
of engineered tissue. It is only in flex-flow states that both shear stress 
magnitude and OSS will be augmented. Thus in the current study, our primary 
objective was to computationally quantify specimen surface: (1) shear stress 
magnitudes and (2) OSS present under, i) No flow, no flexure (control group) ii) 
steady flow-alone, iii) cyclic flexure-alone and iv) flex-flow states, and to 
subsequently co-relate them to previous experimental studies on engineered 
collagen production (Engelmayr et al., 2006) under these four corresponding 
culturing environments. 
4.2   Methods 
4.2.1   Overview 
Computational Fluid dynamic (CFD) simulations of a flow-stretch-flexure 
(FSF) bioreactor available in our laboratory were performed. The physical 
description of the FSF bioreactor has been provided in detail previously 
(Boronyak et al., 2009; Ramaswamy et al., 2009a; Ramaswamy et al., 2013; 
Ramaswamy et al., 2008). The FSF bioreactor modeled in the present study is 
distinct from, but based on, the first FSF bioreactor, originally developed and 
reported by Engelmayr et al. (Engelmayr et al., 2008; Engelmayr et al., 2006). 
Briefly, the new device (Figure 13) can induce FSF stresses at the physiological 
range for up to three rectangular scaffolds per conditioning chamber without 
using viscosity additives. The complete set up comprises of four chambers. The 
sample movement is generated by an external actuator, and the flow is induced 
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through a peristaltic pump. As mentioned, the individual and combined effects of 
steady flow and sample cyclic flexure on the regional flow physics of rectangular 
scaffolds were simulated in four cases.  
 
 
 
 
 
 
 
 
 
 
Figure 13: a) Shows a single bioreactor chamber connected to media source. 
The media is pumped into the bioreactor by a peristaltic pump (Boronyak et al., 
2009; Ramaswamy et al., 2009a; Ramaswamy et al., 2009b; Ramaswamy et al., 
2010; Ramaswamy et al., 2011; Ramaswamy et al., 2014). An external actuator 
attached to one end of the samples provides movement. b) Shows an inside look 
of the bioreactor. The chamber can hold three specimens. Each sample has one 
end fixed while the other is allowed to move linearly by means of the actuator.    
 
4.2.2   Mesh Construction, Simulation Set-up 
A 3D virtual geometry of the bioreactor’s fluid domain was created (Design 
Modeler, Ansys Inc., Canonsburg, PA). The domain sample dimensions were 17 
X 6.5 X 1 (mm). A quadrilateral-element, structured mesh was subsequently 
constructed (Ansys Meshing, Ansys Inc., Canonsburg, PA). Since we were 
Media 
Source 
Pump 
 
Actuator 
Inlet 
Outlet 
Moving posts 
Fixed posts 
Direction of linear motion 
a) 
b) 
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looking at the flow patterns-alone, the samples were suppressed after meshing 
and only the mesh for the fluid domain was imported into the CFD software for 
simulations (CFX 14.5 version, Ansys Inc, Canonsburg, PA). All simulations 
performed in this study imposed a Newtonian, viscous model, with laminar flow 
conditions and the following material parameters: the physical properties for 
bioreactor media were used with density = 1.01g/cm3 and dynamic Viscosity = 
1.27 cp. A zero relative-pressure condition was also applied at the outlet. Finally, 
a no slip boundary condition was prescribed to the bioreactor walls and also to 
the samples, for the cases where they did not move (no flow, no flexure and 
steady flow-alone). In all the CFD simulation runs, the models were analyzed 
once a convergence criteria of 1x10-9 for the momentum and continuity equations 
were achieved. Simulations were conducted in a Hewlett Packard work station 
with intel(R) Xeon(R) CPU, x5550@ 2.67GHz (2 processors) with 16.0 GB 
installed memory and 64-bit windows 7 operating system. 
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Figure 14: a) Depicts the entire fluid domain of the bioreactor chamber. Note the 
three scaffolds in a straight configuration and the plane (in red) at x = 0.075m 
corresponding to the longitudinal center line of the samples. b) Cross section (x 
=0.0175m) of the structured mesh (which consisted of 441,370 elements and 
472,728 nodes) showing the distribution of quadrilateral elements and nodes. 
Note that the element density is higher around the samples and lower as it 
approaches the outlet. c) A close-up of the mesh around a single sample. The 
elements around the vicinity of the samples were aligned to conform to the 
flexing shape of the specimens. d) Close-up of the sample edge during t = 0s, t 
=0.25 s, t =0.5 s, t = 0.75 s, t = 1 s. 
 
4.2.3   Mesh Independence 
A similar simulation of the steady flow-alone case has been described in 
previous efforts (Salinas et al., 2014a; Salinas et al., 2014b). In that investigation, 
a relatively fine tetrahedral mesh consisting of 3.1x106 elements and 5.5x105 
nodes was employed. The results revealed that the sample area-averaged shear 
stress was 0.031 Pa. We continued optimizing our structured mesh density until 
 
     
 
 
t =0 sec t =1 sec t =0.75 sec t =0.5 sec t =0.25 sec 
b) 
d) 
c)  
 
t =0 sec t =0.5 sec 
a) 
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a mesh consisting of 441,370 quadrilateral elements and 472,728 nodes (Figure 
14) computed a corresponding average shear stress value that was found to be 
within 2% variability. This mesh was subsequently employed for all succeeding 
CFD simulations.  
4.2.4   Simulations involving non-moving samples (no flow, no flexure and 
steady flow-alone) 
In the control group, the samples were non-moving and an inlet flow 
velocity of negligible quantity was prescribed (1x10-7m/s). For the steady flow 
case, the samples were still held stationary and an inlet plug velocity profile of 
0.022 m/s was prescribed. Peak flow velocities in previous FSF bioreactor 
studies (Engelmayr et al., 2008) were determined to be in the order of 0.08 m/s. 
In the current computational study, we chose to prescribe an inlet velocity of 
0.022 m/s which represents a time-averaged blood velocity in the pulmonary 
artery (Lotz et al., 2002) and therefore is of particular physiological relevance to 
tissue engineered pulmonary valves. This prescribed velocity can readily be 
faciltiated by the flow source (Boronyak et al., 2009; Ramaswamy et al., 2009a; 
Ramaswamy et al., 2009b; Ramaswamy et al., 2010; Ramaswamy et al., 2011; 
Ramaswamy et al., 2014) of the FSF bioreactor modeled in this study. Three 
fixed specimen configurations were simulated in the steady flow-alone case: fully 
straight, semi-bent, and fully bent.  These snapshot configurations corresponded 
to the initial, mid and final specimen shapes during the bending event. 
  
 
66 
 
4.2.5   Simulations involving moving samples (cyclic flexure-alone and flex-
flow) 
In the CFD simulations for cyclic flexure-alone, the samples were allowed 
to bend, but the inlet velocity was set to zero.  In the flex-flow simulation, the 
samples were flexed and the inlet plug velocity profile was set to 0.022 m/s. The 
set up and simulation of the flex-flow case is described in detail in (Ramaswamy 
et al., 2014). In brief, the samples were assumed to bend as a parabola. The 
construct deformed from a straight to bent configuration in 0.5 s, and then from a 
fully bent to straight state in the next 0.5 s. At a time step of 2 ms, the samples 
were re-meshed to represent the change in sample shape while its movement 
was incorporated using an Arbitrary Lagrange Eularian (ALE) approach. 
Specifically, the ALE formulation uses a grid velocity which is coupled to the flow 
equations via the space conservation law. Details concerning the ALE 
formulation has been reported previously (Ansys, 2014; Lai and Przekwas, 1994; 
Ramaswamy et al., 2004). In brief, the continuity equation and the fully, time 
dependent, 3-D Navier-Stokes equations (inertial frame of reference) for an 
incompressible viscous fluid are: 
     .V = 0 Eq. 91     
    V/t + (V.)V = -1/(p)+ 2V  Eq. 92 
Where, V is the velocity vector, p is the pressure, t is the time,  is the fluid 
density, and  is the kinematic viscosity. To permit motion, the ALE formulation 
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introduces a grid velocity (Vg) in equations 1 and 2 to impose an additional 
geometric constraint which is expressed in integral form as: 
     d/dtd = sVg.ds  Eq. 93   
Note that Vg is known a priori which in our case was identified as we have 
previously reported by us (Salinas et al., 2012; Salinas et al., 2014b), as follows: 
The FSF bioreactor specimens were assumed to take on a parabolic shape and 
fit to the equation of an arc, given by: 
                                                           ∫ √                 
 
    
 Eq. 94 
Where b is the new position of the moving post as it moves to the stationary post 
and C is the nonlinear parabolic constant. The specimen length was fixed at 17 
mm. The constant, ―C‖ was computed numerically (Mathcad® v.15, PTC, 
Needham, MA) over the 250 time steps. The continuity and momentum 
equations with Vg incorporated can be re-expressed as: 
    d/dtd + s(V – Vg) .ds = 0   Eq. 95 
  d/dtVd + s V(V – Vg) .ds = s ij.ds Eq. 96 
Where,  is the arbitrarily moving control volume, S is the surface of , and ij is 
the second order stress tensor. With Vg now known, we wrote a script interfaced 
to the main CFD software (CFX, Ansys Inc.), such that a numerical solution could 
be computed at a given temporal position, for the moving mesh. 
In addition to satisfying the convergence criteria (1 x 10-9) for the 
momentum and continuity equations, the final solution convergence was 
accomplished once the mesh displacement equations also satisfied the 
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prescribed residual value of 1x10-9. We note that for the dynamic simulations 
cyclic independence was achieved in the second cycle from which the results 
were analyzed, since a less than 5% difference was found when comparing the 
average specimen shear stress between the 2nd and 3rd cycles. 
4.2.6   Validation Studies 
4.2.6.1 CFD Simulation of a moving indentation in a 2-D Channel 
Pedley and Stephanoff (Pedley and Stephanoff, 1985) conducted an in 
vitro experiment aimed at understanding the incompressible fluid flow through 
collapsible tubes such as arteries and veins. In their experiment, A 100mm x 
100mm plate was pushed into a Poiseulle laminar flow, creating vortices. The 
total length and height of the channel was 410 mm, and 10 mm, respectively. 
Vortex characteristics were governed by the Strouhal and Reynolds numbers in 
addition to the degree of indentation. 
 
Figure 15. Schematic representation of the 2-D channel used in the experiment. 
Source: Lai Y.G., and Przekwas A.J., (1994). A Finite-Volume Method for Fluid 
Flow Simulations with Moving Boundaries. Computational Fluid Dynamics, 
Volume 2., pp. 19-40. 
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The motion of the wall is governed by the following 2-D Cartesian equations: 
Y(x) = h                                 for 0<x<x1  Eq. 97 
Y(x) = 0.5h {1-th [a(x-x2)]}     for x1<x<x3   Eq. 98 
Y(x) = 0                                 for x>x3  Eq. 99 
Where a = 4.14 cm;  
h = 0.5hmax [1-cos(2πt*)]   Eq. 100 
t* = t-to/T, hmax=0.38, T = 5.33 (s) Eq. 101 
The Reynolds number (Re) based on the inlet bulk velocity (U) and channel width 
(b) was Re= 507. The Struohal number (St) was St = b/UT = 0.037. 
Here we demonstrated that the CFD engine from CFX ® (Ansys, 
Canonsburg, PA) can calculate the flow physics shown in the visualization 
experiments (Pedley and Stephanoff, 1985). A fully structured mesh of the 
channel was created comprising of 20,000 elements as seen in Figure 16. The 
mesh after the deformation can be observed in Figure 17. In the simulations, the 
inlet velocity was 65.789 mm/sec, density was set to 1000 kg/m3, viscosity was 
1.079x10-3 Pa.s, and the time step used was 0.01 sec. Using the equations that 
govern the plate displacement, we implemented a moving boundary simulation. 
They reported the results as a function of normalized time where 0 was the 
beginning of the cycle and 1 was the end of the cycle. One cycle was equal to 4 
seconds. The time steps specified was t* = 0.01. The simulation was run during 
four cycles to allow for periodicity. 
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Figure 16. CFD Mesh – 20,000 Hexagonal Elements. 0 seconds (undeformed). 
 
 
Figure 17.  CFD Mesh – 20,000 Hexagonal Elements.  
Pedley and Stepanoff (Pedley and Stephanoff, 1985) observed that the 
flow was unidirectional for the first 0.34 normalized time. At 0 the experiment 
showed a single recirculation region. Existence of multiple eddies where reported 
in following times as shown in Figure 18.  CFD velocity vector plots are shown in 
Figure 19 where it can be seen that CFX ® (Ansys, Canonsburg, PA) was able to 
precisely replicate the flow vortices observed during the flows visualization 
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experiments performed by Pedley and Stephanoff (Pedley and Stephanoff, 
1985). 
 
Figure 18. Simplified sketch of the flow patterns observed by (Pedley and 
Stephanoff, 1985). Source: Pedley T.J. and Stephanoff K.D., (1985), Flow along 
a Channel with a Time-Dependent Indentation in One Wall: the Generation of 
Vorticitv Waves. Journalof Fluid Mechanics, Volume 160, pp.337-367. 
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Figure 19. CFD replication of flow experiments performed by (Pedley and 
Stephanoff, 1985). 
 
4.2.6.2 CFD validation of specimen dynamic simulations 
We compared our shear stress results (time step = 2 ms) for our flex-flow 
simulations with a similar dynamic simulation (time step = 0.5 ms) conducted by 
Ramaswamy et al. (Ramaswamy et al., 2014) which employed a custom-written 
code based on the immersed boundary method and utilized a sample with 
dimensions of 1mm x 7 mm x 25 mm. In this study, our sample utilized 
dimensions of 1mm x 6.5 mm x 17 mm. Our results for shear stress were found 
A 0.34  
B 0.41 
C 0.48  
D 0.55 
E 0.62 
F 0.69 
G 0.76 
H 0.84 
I 0.91 
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to be within 10% of the previously reported shear stress and thus in good 
agreement. 
The justification of a 2ms time step in the current study can be further 
explained as follows: previously, we conducted a time independence study 
(Salinas et al., 2014a; Salinas et al., 2014b) of CFD simulations involving the 
FSF bioreactor using time steps of 0.5 msec, 1 msec, 2 msec, and 4 msec. The 
results showed no significant differences in the shear stress profiles (~less than 
2% variability). In light of this fact, we applied a 2 msec time step for capturing 
the flow physics of the FSF, u-shaped bioreactor. We observe that in addition, 
there are several works that have previously reported CFD results obtained from 
simulations run using FSF-type bioreactor geometries, implementing a 2 msec 
time step (Salinas and Ramaswamy, 2014; Salinas et al., 2014b; Salinas et al., 
2014a; Ramaswamy et al., 2014; Boronyak et al., 2009; Ramaswamy et al., 
2008; Engelmayr et al., 2008).  
We further note that a useful parameter that can aid in determining the 
most appropriate time step is the the courant number (CFL). It is given by: 
    ∑
   
   
     
 
     
Where the dimensionless number is called the Courant number,  is the 
magnitude of the velocity (length/time);  is the time step (time);  is the 
length interval (length). A CFL number that has a value of less than one is 
important in order to achieve convergence of the finite difference approximation.  
The courant number (CFL) in all of our simulations was below 0.95 and thus in 
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compliance with acceptable convergence of the governing equations in the CFD 
studies we performed.   
Going back to the study that utilized the IBM to resolve the flow field in the 
FSF, u-shaped bioreactor (Ramaswamy et al., 2014) we strongly believe that the 
10% difference in shear stresses that was found compared to our corresponding 
simulation was mainly due to the differences in sample dimensions and the time 
steps between the two investigations. Nonetheless, we state that the simulations 
performed by (Ramaswamy et al., 2014) were highly precise while comparatively, 
the ones conducted in this study were still within a reasonable degree of 
accuracy (10%) and could thus be used to evaluate relative flow physics among 
the different bioreactor CFD simulations conducted (e.g. combined cyclic 
specimen flexure and steady flow versus cyclic flexure-alone). 
4.3   Results 
The fluid-induced, time averaged axial shear stresses were plotted on the 
inner and outer surfaces for all the simulation cases (Figure 20). The values were 
found to be higher on the outer wall for all cases except the control (no flow, no 
flexure) wherein they were essentially the same on both walls. The highest shear 
stress values were observed to occur at the vertex of the samples. This finding is 
consistent with the previous report by (Engelmayr et al., 2008). In addition, the 
prediction of amplified wall shear stresses at the vertex of the samples was 
indicated in (Engelmayr et al., 2006) as a potential mediator of tissue formation.  
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Also, the flex-flow simulations showed augmented shear stresses relative 
to steady flow-alone or specimen cyclic flexure-alone.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Fluid-induced, time-averaged axial shear stresses over one cycle on 
specimen inner and outer walls for the following six cases: i) no flow and no 
flexure ii) steady flow-alone (straight sample), iii) steady flow-alone (semi-bent 
sample), iv) steady flow-alone (fully-bent sample), v) cyclic flexure-alone and vi) 
flex-flow states.  Shear stresses were found to be higher along the outer wall 
except in the case of no flow and no flexure. The highest shear stresses were 
observed around the vertex of the sample. In comparing the two dynamic cases 
(v) versus (vi), the flex-flow state displayed much higher shear stress values. 
 
To observe the velocity profiles at a section surrounding the vicinity of the 
samples, a longitudinal cross-sectional plane (x= 0.0175 m) at the center line of 
Inner wall Outer wall 
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Flow direction 
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the specimens was applied (Figure 21). The results showed non-existent to 
modest levels of flow separation in the steady flow-alone cases; when the 
samples were straight the flow was fully unidirectional in the forward flow 
direction (Figure 21a). On the other hand, a few vortices proximal to the inner 
specimen wall were observed in the semi-bent and fully bent configurations.  
Substantially higher flow reversal regions were observed in the case 
involving cyclic flexure-alone (Figure 21b). Complete recirculation zones 
occurred simultaneously with the initiation of sample bending (t = 0 s). Loss of 
uniformity in the size and pattern of vortices in the flow field increased at 
subsequent time steps. In addition, the velocity streamlines were different during 
the bending (t = 0.25 s) and unbending (t = 0.75 s) events, even though the 
sample configurations at these time instances were identical. Meanwhile, in the 
flex-flow case (Figure 21c), the number of flow vortices increased with the 
specimen flexure states but was not as pronounced as those observed in 
comparison to cyclic flexure-alone (Figure 21b). On the other hand, in the flex-
flow environment, there was greater variability in the axial velocity distribution.  
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Figure 21: Contour of velocity magnitudes and velocity streamlines in the plane 
(x= 17.5 mm) surrounding the specimens for the following cases: a) steady flow-
alone (straight sample), b) cyclic flexure-alone and c) flex-flow states.  The inlet 
velocity for a) and c) was set to 0.022 m/s while for b) it was set to 0 m/s.  A large 
degree of vortices formed in cyclic flexure-alone case, but the magnitude of 
velocity field was clearly lower when compared to steady flow-alone and flex-flow 
cases. It was also noted that the flow physics during the specimen flexing and 
straightening events (in both b) and c) at the instance when the specimen shape 
was identical, i.e., at t =0.25 and 0.75 s respectively were not the same.  
 
In order to quantify the extent of directionality changes in the temporal 
shear stress experienced by the samples, i.e., OSS under cyclic flexure-alone 
and flex-flow conditioning, the oscillatory shear index (OSI) was calculated. As 
previously defined by He and Ku (He and Ku, 1996) the equation for the OSI is 
given by: 
Flow direction 
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  Eq. 102 
 
Where,    (∫    )
 
 
 is the magnitude of the time-averaged shear stress while 
∫    ( )  
 
 
 is the time-averaged shear stress magnitude. One can observe that: 
0.0  OSI  0.5, where an OSI = 0.0 represents unidirectional flow while OSI = 
0.5 signifies complete oscillatory flow. 
Consistent with the axial velocity plots (Figure 21), the OSI distribution 
was found to be much higher when exposed to cyclic flexure-alone, relative to 
flex-flow conditions (Figure 22a). The area averaged OSI on the specimen inner 
walls (n=3) was 0.433 and 0.230 for cyclic flexure-alone and flex-flow cases 
respectively while the corresponding values for the outer wall (n=3) was found to 
be 0.313 and 0.076. For the dynamic simulations, as a means to represent the 
coupled effects of shear stress magnitude and OSS, we defined the product of a 
specimen’s OSI distribution and its corresponding time averaged shear stress 
magnitude (TSSM), multiplied by a factor of two, as the ―OSI-scaled shear stress 
magnitude‖ (OSI-   ⃗⃗ ⃗⃗ ), i.e.,: 
OSI-   ⃗⃗ ⃗⃗   = 2 * OSI * TSSM  Eq. 103 
The OSI-   ⃗⃗ ⃗⃗  distribution was in general, relatively higher on the specimen 
surfaces (Figure 22b) under flex-flow states compared to cyclic flexure-alone. 
The area averaged OSI-   ⃗⃗ ⃗⃗  for the inner walls were 0.01 Pa (cyclic flexure-alone) 
and 0.066 Pa (flex-flow) while for the outer walls these were 0.016 Pa (cyclic 
flexure-alone) and 0.028 Pa (flex-flow).  
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Figure 22: a) OSI on the inner and outer specimen surface for the dynamic cyclic 
flexure-alone and flex-flow cases.  The node averaged OSI along the inner walls 
were 0.433 (cyclic flexure-alone) and 0.230 (flex-flow) while for the outer walls 
the OSI was 0.313 (cyclic flexure-alone) and 0.076 (flex-flow).   b) OSI-scaled 
shear stress magnitude (osi-   ⃗⃗  ⃗) on the inner and outer specimen surface for the 
dynamic cyclic flexure-alone and flex-flow cases.  The node averaged osi-   ⃗⃗  ⃗ 
along the inner walls were 0.01 Pa (cyclic flexure-alone) and 0.066 Pa (flex-flow) 
while for the outer walls the osi-   ⃗⃗  ⃗ was 0.016 Pa (cyclic flexure-alone) and 0.028 
Pa (flex-flow).  Effectively the osi-   ⃗⃗  ⃗ metric served to combine both the time 
averaged and oscillatory shear stress components, demonstrating that its 
magnitude was much lower in cyclic flexure-alone states compared to flex-flow 
states, even though the OSI of the former was substantially higher compared to 
the latter. 
 
Previously, Engelmayr et al. (Engelmayr et al., 2006) defined a percent 
increase in collagen content relative to the average collagen content of the no 
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flow, no flexure (control group), steady flow-alone, cyclic flexure-alone and flex-
flow groups. When plotting the TSSM, OSI and OSI-   ⃗⃗ ⃗⃗  metrics as a function of 
these previously reported collagen content amounts, only OSI-   ⃗⃗ ⃗⃗  was found to 
be in direct proportion to the substantially augmented engineered collagen that 
had formed when cyclic flexure and steady flow conditions were combined 
(Figure 23). In a similar fashion, we quantified the net % increase in the mean 
TSSM, OSI and OSI-   ⃗⃗ ⃗⃗   parameters that resulted from flex-flow mechanical 
conditioning in comparison to the sum of the corresponding parameter amounts 
resulting from cyclic flexure-alone and steady flow-alone conditioning, as follows: 
           
 
(                  ) (                                                         )
(                                                         )
        Eq. 104 
where ―Parameter‖ Refers to TSSM, OSI or OSI-   ⃗⃗ ⃗⃗    The % increases for TSSM, 
OSI and OSI-   ⃗⃗ ⃗⃗   were found to be, 27.65%, -37.19%, and 207.14% respectively. 
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Figure 23: For the following three cases of 1) steady flow-alone (straight sample), 
2) cyclic flexure-alone and 3) flex-flow states, the specimen area mean: a) 
TSSM, b) OSI and c) OSI-  ⃗ | was plotted vs. the percentage (%) collagen 
increase. In a) b) and c), the % increase in collagen was observed relative to the 
average of the sum of no flexure and no flow, steady flow-alone (straight sample) 
and cyclic flexure-alone, as previously reported by (Engelmayr et al., 2006) Only 
the OSI-  ⃗ | parameter demonstrated a convincing correlation to the collagen 
production found in flex-flow states (Engelmayr et al., 2006), which resulted in 
significantly higher engineered tissue collagen content. 
 
4.4   Discussion 
Shear stress is known to be an important promoter of engineered tissue 
formation (Engelmayr et al., 2008; Engelmayr et al., 2006; Karim et al., 2006). In 
addition to the magnitude of these stresses, studies have independently 
suggested that temporal changes in the directionality of shear stress, i.e., OSS is 
also critical for promoting tissue formation and phenotype (Li et al., 2004; 
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Ramaswamy et al., 2010). For example, the importance of OSS has directly been 
associated with the regulation of the KLF2-a gene which is essential for normal 
valvulogenesis (Vermot et al., 2009).  
In this study we sought to computationally simulate the localized flow 
physics surrounding engineered tissue specimens that could have ultimately 
been responsible for the significant increases in collagen tissue production 
reported in previous heart valve tissue engineering investigations, under the 
combination of steady flow and sample cyclic flexure (Engelmayr et al., 2006). 
Thus, in this investigation, we simulated, no flow-no flexure (control) , steady 
flow-alone, cyclic flexure-alone and flex-flow conditions of samples that 
underwent mechanical conditioning in a bioreactor; to incorporate the bending 
motion of the samples, the cyclic flexure-alone and flex-flow simulations both 
required moving boundary computational simulations which we implemented 
using the ALE formulation.  
Previously Engelmayr et al. (Engelmayr et al., 2008) predicted that the 
peak wall shear stress magnitudes on rectangular-shaped specimens occurred at 
the upstream, convex edge of the flexed samples and approached 1 Pa, while 
the corresponding average value was 0.182 Pa. In this study, the peak wall shear 
stress magnitude was found to be 0.30 Pa, occurring at the same spatial location 
on the specimens (specimen vertex along the outer wall, steady flow-alone, fully-
bent case; Figure 20), while the average wall shear stress magnitude was 0.05 
Pa.  As observed in both current and previous investigations (Engelmayr et al., 
2008) on conditioned rectangular-shaped, flexed specimens, the peak specimen 
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shear stress magnitudes were roughly five to six times higher than the average. 
However, the shear stress magnitudes in the current study were much lower than 
those reported by Engelmayr et al. (Engelmayr et al., 2008) primarily because of 
the relatively lower inlet velocity boundary condition that was prescribed (0.022 
m/s here versus 0.08 by (Engelmayr et al., 2008). Our inlet velocity was based 
on the time-averaged flow conditions of the human pulmonary artery (Lotz et al., 
2002). 
The major novelty of our study is that we identified a new biomechanical 
parameter in the form of a scaled OSI (OSI-   ⃗⃗ ⃗⃗  ) that correlates with the previously 
reported observation (Engelmayr et al., 2006) that, greatly augmented 
engineered collagen formation occurred solely when steady flow and cyclic 
flexure were combined, i.e. the flex-flow state. On the other hand, neither TSSM 
nor OSI alone could convincingly explain the large increases in collagen content 
derived from this flex-flow activity.  
Clearly OSI-   ⃗⃗ ⃗⃗  yielded a much higher value, roughly 7.5 times larger than 
the percent increase in TSSM alone (Figure 23a). On the other hand, any 
correlation with OSS proved to be incorrect since the combined flex-flow states 
suggested less engineered collagen content relative to the cyclic flexure-alone 
case (Figure 23b). We believe that the reason for this was because, while 
specimen cyclic flexure-alone is highly effective at generating OSS (Fig 17a), it is 
obviously not accompanied by appreciable shear stress magnitudes, which are 
typically facilitated by a flow source, such as a pump. Specifically, the case of 
cyclic flexure-alone comprises of relatively low magnitudes of fluid shear stress 
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arising only from the motion of the cyclically flexing specimens in an effectively 
static fluid bath. Clearly, this is an example of a mechanical conditioning 
environment of relevance to heart valve tissue engineering where the OSS is 
high but the shear stresses are low, which previously led to insignificant levels of 
engineered tissue content, relative to no flow, no flexure static controls 
(Engelmayr et al., 2006). This observation demonstrates yet again that the co-
existence of both metrics, i.e., OSS and TSSM are important for engineered 
collagen formation. 
The % increase reported by Engelmayr et al. (Engelmayr et al., 2006) in 
engineered collagen production under flex-flow states compared to the average 
collagen content of the no flow, no flexure, steady flow-alone and cyclic flexure-
alone conditions was 75% whereas the corresponding increase for the sum of 
independent cyclic flexure-alone and steady flow-alone was only 42%. Similarly, 
the OSI-   ⃗⃗ ⃗⃗  quantity under flex-flow states was 0.044 Pa while the corresponding 
value for the sum of independent cyclic flexure-alone and steady flow-alone was 
0.014 Pa. In other words, significant increases in engineered collagen content 
under flex-flow states correlated with an appreciable, corresponding increase in 
the OSI-   ⃗⃗ ⃗⃗   parameter (Figure 23c).  
The goal of the OSI-   ⃗⃗ ⃗⃗   parameter is to emphasize that BOTH the time-
averaged shear stress magnitude (    ) and OSI are important in promoting 
engineered heart valve tissue formation as was previously observed in the 
experiments of Engelmayr et al. (Engelmayr et al., 2006). As a result we define 
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OSI-   ⃗⃗ ⃗⃗   as a single index that can capture the necessity for both OSI and      
metrics to be present during heart valve tissue engineering experiments. A factor 
of two is multiplied in the definition of OSI-   ⃗⃗ ⃗⃗   for the following reason: When the 
OSI is maximum, i.e., OSI = 0.5, the OSI-   ⃗⃗ ⃗⃗   simply reduces to     . On the 
other hand, as one would observe during steady flow-alone or cyclic flexure-
alone mechanical conditions, OSI-   ⃗⃗ ⃗⃗   would be zero and negligible respectively. 
We note again that the findings of Engelmayr et al. (Engelmayr et al., 2006) 
suggested that neither steady flow-alone or cyclic flexure-alone showed any 
significant augmentation in engineered collagen formation compared to static 
tissue culture (no flow-no flexure, control group). Therefore indeed, in these 
cases, we would expect that the biomechanical conditioning ―effect‖ of OSI-   ⃗⃗ ⃗⃗   to 
be zero or negligible. Thus, we have in a simple way shown that neither      
nor OSI alone can convincingly explain significant increases in collagen 
production that Engelmayr et al. (Engelmayr et al., 2006) reported under a 
combination of flex-flow states. On the other hand, the combination of these two 
parameters, characterized by OSI-   ⃗⃗ ⃗⃗   does capture the synergy of the flex-flow 
state (in the context of promoting engineered collagen production activity). In the 
flex-flow case the average specimen OSI was not a maximum of 0.5 but was 
instead found to be  0.23. Thus, the OSI-   ⃗⃗ ⃗⃗   parameter served to reduce the 
mechanical conditioning ―effect‖ of     , by a factor of 0.46 (i.e., 2 * OSI), in the 
flex-flow case. 
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We note however that OSI-   ⃗⃗ ⃗⃗   needs to be interpreted in a relative rather 
than an absolute context, for example in comparing flex-flow versus steady flow-
alone or versus cyclic flexure-alone. Certainly the magnitude of      and OSI 
can have independent effects on the amount of engineered tissue formation. 
However, this amount when obtained from a steady flow-alone (    -only) or 
cyclic flexure-alone (OSI-only) experiment will always be small relative to a 
corresponding experiment conducted under flex-flow states (both      and OSI) 
which utilizes the same magnitude of      and OSI as when they were used 
independently. In addition, in this first approximation study, the OSI-   ⃗⃗ ⃗⃗   metric 
also assumed that both OSI and      are equally important, although this 
remains to be proven. Finally, since the Engelmayr et al. (Engelmayr et al., 2006) 
study was based on bone marrow stem cells (BMSCs) the interpretation of OSI-
   ⃗⃗ ⃗⃗   can for the time-being only be used for this cell type since the response of 
other cell types to mechanical stimuli and subsequent rates of engineered 
collagen synthesis may be different. We believe nonetheless that this distinction, 
i.e., OSI-   ⃗⃗ ⃗⃗  is important (as opposed to simply TSSM alone or OSS alone). This 
is because OSS can be generated without a flow source and purely through 
specimen movement, while non-moving specimens exposed to a steady flow 
source that generate physiological-levels of shear stresses are not exposed to 
oscillatory effects; yet the simultaneous presence of shear stress magnitude and 
temporal changes to the directionality in flow seem to be required to promote 
engineered heart valve tissue formation. 
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In conclusion, we present a modification of the traditional OSI parameter 
first defined by He and Ku (He and Ku, 1996), by multiplying it to its spatially 
corresponding time-averaged, fluid-induced shear stress quantity (TSSM) and by 
a factor of two. In doing so, we were able to demonstrate that the combination of 
both parameters (OSI-   ⃗⃗ ⃗⃗ ) correlated strongly with the greatly augmented 
engineered collagen production reported from previous in vitro experiments 
(Engelmayr et al., 2006), under flex-flow conditioning regimens. We wish to 
emphasize however, that a limitation of our study was that the OSI-   ⃗⃗ ⃗⃗  metric we 
defined assumed that both OSI and TSSM are equally important, but this may or 
may not be the case and remains to be determined. Our principal goal behind 
OSI-   ⃗⃗ ⃗⃗   was to demonstrate that both the magnitude and directionality (i.e., 
oscillations) of the fluid-induced shear stresses are critical in augmenting tissue 
formation, rather than to arrive at a precise metric that can be used to quantify 
the relative contributions of OSI and TSSM.  Indeed as stated earlier, our 
definition of OSI-   ⃗⃗ ⃗⃗  is by no means an ideal metric and remains at best, a crude 
approximation. Nonetheless, in this particular study OSI-   ⃗⃗ ⃗⃗  did correlate with 
increased collagen formation.   However given that there is a dependence on the 
biological response of different cell types to mechanical environments, the 
correlation could be altered if cells other than BMSCs are used in the tissue 
engineering experiments.  
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CHAPTER 5: MASS TRANSPORT MODEL 
The most severe forms of congenital heart disease have an incidence rate 
of  20,000 live births/year (Hoffman, 1995). A large number of these cases 
present with problems associated with the heart valves.  Moreover, an estimated 
104,000 valve procedures are performed in the US (Roger et al., 2011) alone 
annually and this number continues to grow each year.  Today, replacement of a 
defective valve with a prosthetic heart valve is commonplace in adult and 
pediatric patients. However, despite recent advances in medical technology, 
distinct limitations remain in the current treatment of critical, congenital heart 
valve disease. Even though prosthetic valves are currently used to replace 
defective valves, no currently available treatment option provides a permanent 
solution.  Among the pediatric population, the situation is further aggravated by 
the inability of the valve substitute to permit somatic growth thus necessitating 
the child to undergo multiple invasive operations.  From a research standpoint, 
functional, organ-level, tissue engineered heart valve (TEHV) replacement which 
would permit somatic growth and would not pose any immune risks was thought 
to represent the Holy Grail in treating valve disease. For example, extensive work 
in the heart valve tissue engineering area has been conducted by the Mayer and 
Hoerstrup groups (Hoerstrup et al., 2000a; Hoerstrup et al., 2000b; Hoerstrup et 
al., 1998; Hoerstrup et al., 1999; Sodian et al., 2000a; Sodian et al., 1999; 
Sodian et al., 2000b; Sodian et al., 2000c). They showed that when implanted in 
the pulmonary artery position, TEHVs functioned (observed for four months) in 
growing lambs, exhibiting durability, growth, and lack of thrombogenicity 
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(Hoerstrup et al., 2000a; Sutherland et al., 2005). Yet, after more than a decade 
of intensive TEHV investigations which included clinical studies (Dohmen et al., 
2011), identification of a specific protocol for optimized construct development 
which can subsequently be clinically translated remains elusive.  While potential 
cell sources and scaffold materials for heart valve tissue engineering have been 
identified (Chen and Wu, 2005; Fong et al., 2006; Frank et al., ; Hilfiker et al., 
2011; Kadner et al., 2002; Leor et al., 2005; Lichtenberg et al., 2006; Martinez et 
al., 2013; Neuenschwander and P. Hoerstrup, 2004; Perry et al., 2003; Schmidt 
et al., 2006; Schmidt et al., 2010; Siepe et al., 2008; Simon et al., 2006; Weber et 
al., 2011a; Weber et al., 2011b), the biomechanical conditions needed to 
promote the heart valve phenotype still require further investigation.  In addition, 
cellular responses to the applied mechanical stresses will undoubtedly depend 
on the cell type(s) being utilized; adult progenitor cells, such as bone marrow 
derived stem cells (BMSCs) are deemed likely candidates for utility in heart valve 
tissue engineering owing to their pluripotency, ease of access and lack of ethical 
concerns.  Given that valvulogenesis is closely tied to its surrounding 
hemodynamics, it has been generally accepted that this biomechanical 
environment to the extent possible, be recapitulated during engineered heart 
valve tissue culture.  However, the specifics such as the manner in which 
mechanical stresses need to be applied, the necessity to deform the growing 
construct similar to a native valve and the duration of the culture process remain 
uncertain.  
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 To further understand in vivo native heart valve stress environments, 
several efforts have focused on the innate stresses that native heart valves are 
subjected to, namely, fluid-induced shear stresses and the cyclic tissue stretch 
and flexure events that occur during valve opening and closure.   Specifically, 
custom-made heart valve bioreactors have been used to study the individual or 
combined effects of these stresses on engineered tissue formation (Engelmayr et 
al., 2003; Engelmayr et al., 2008; Ramaswamy et al., 2014; Ruel and Lachance, 
2009), while computer simulations have focused on the quantification of stress 
states on valvular tissues (Engelmayr et al., 2008; Ramaswamy et al., 2014; 
Salinas et al., 2014a; Salinas et al., 2014b; Salinas and Ramaswamy, 2014; 
Stella et al., 2007). Some of the key mechanobiological findings were as follows: 
Engelmayr et al (Engelmayr et al., 2006) showed that BMSCs cultured under 
conditions of flow and scaffold flexure produced more collagen than conditions of 
flow or cyclic flexure-alone. Vermot et al. (Vermot et al., 2009) reported that 
oscillatory shear stresses (OSS) directly regulated the gene klf2a which is 
required for normal valve development.  We previously showed (Salinas and 
Ramaswamy, 2014) that robust collagen production from the combination of 
cyclic flexure and steady flow states (flex-flow) (Engelmayr et al., 2006) was a 
direct result of an appreciable shear stress magnitude tied to a high degree of 
flow oscillations, i.e., OSS. Moreover we also demonstrated that these types of 
OSS environments can be recreated under pulsatile flow conditions wherein the 
samples are fixed, i.e., do not move (Salinas et al., 2014a; Salinas et al., 2014b). 
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The specific biomechanical environments used in the culture of 
engineered heart valve tissues will contribute towards  the transport of nutrients 
and removal of metabolic waste products from the growing constructs (Brown et 
al., 2007; Chen et al., 2014; Ramaswamy et al., 2014; Salinas and Ramaswamy, 
2014; Syedain, 2009b).  Such transport is critical to the survival of cells, their 
phenotypic stability and subsequently the robustness of extracellular matrix that 
is produced.  Indeed it has been shown that without adequate, homogeneous 
delivery of nutrients within cultured tissues, cell and matrix content will be 
adversely affected (Wang et al., 2008; Wang et al., 2011), with an overall 
decrease in the rate of its production. 
 Although mass transport in tissue culture involves multiple biochemical 
species, studies focused on other tissue types, such as skin, cartilage, ocular-
tissues, and blood vessels have clearly established the importance of adequate 
oxygen (Abraham et al., 2013; Ai and Vafai, 2006; Chung and Vafai, ; Chung and 
Vafai, 2013; de Monte et al., 2013; Denny and Walsh, ; Ethier and Moore, 1997; 
Gill et al., 2011; Johnson et al., 2009; Kaazempur-Mofrad et al., 2005; Karner 
and Perktold, 2000; Khakpour and Vafai, 2008; Kumar et al., 2004; Liu et al., 
2011; Prosi et al., 2005; Stangeby and Ethier, 2002; Tarbell et al., 1988; Wang et 
al., 2009) and glucose delivery. (Boubriak et al., 2006; Converti et al., 1996; Day 
et al., 2013; Gao and Xu, 2011; Koutny, 2011a; Koutny, 2011b; Martineau, 2012; 
Mokhbi Soukane et al., 2007).  
Biochemical species is supplied to living tissues viatwo mechanisms: the 
first is convective mass transport while the second is through diffusive processes 
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(Stangeby and Ethier, 2002; Yang and Vafai, 2006). Convective nutrient delivery 
is associated with pressure-driven transmural flow while the diffusive process is 
initiated by species-specific concentration gradients (Ai and Vafai, 2006; Ethier 
and Moore, 1997). These gradients are caused by nutrient consumption and 
production of metabolic wastes by the cells embedded within the tissues (Chung 
and Vafai, ). Mass transport models thus far have focused primarily on studying 
the distribution of oxygen in heart valve tissues due to convection and diffusion 
(Brown et al., 2007; Chen et al., 2014; Liu et al., 2011; Wang et al., 2008; Wang 
et al., 2011). However, they were limited to simplified diffusion models or did not 
account for oxygen consumption rates by cells.  Moreover heart valve tissue 
engineering protocols typically employ a mechanical conditioning protocol 
wherein a flow and/or specimen movement (e.g. cyclic flexure) component is 
present (Engelmayr et al., 2006; Ramaswamy et al., 2010) the convective-
diffusive processes that occur in these settings have thus far not been identified, 
but may play a critical role in maintaining construct viability for subsequent 
implantation.  
From a biomechanics standpoint, we recently identified (Salinas and 
Ramaswamy, 2014) that measurable quantities of fluid-induced stresses 
accompanied by an oscillatory component were strongly correlated to the 
significantly higher collagen content found in constructs that were subjected to 
the combination of steady flow and specimen cyclic flexure (flex-flow) (Engelmayr 
et al., 2006). However, since these samples were moving, the enhanced tissue 
production may not have been due to only biomechanical effects; rather, the 
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evolution of de novo tissues in dynamic culture systems involving conditions such 
as flex-flow may also be modulated by the efficiency of the mass transport 
mechanism(s).  Therefore in this study, we built on our previous computational 
fluid dynamics (CFD) models (Salinas and Ramaswamy, 2014) to include mass 
transport components, specifically in the delivery of glucose and oxygen to the 
growing 3-dimensional (3D) engineered tissues.  We correlated these findings 
with literature in vitro experiments (Engelmayr et al., 2006). 
5.1 Methods 
5.1.1 Geometry, Mesh, and Simulation Set-up 
We modeled the FSF bioreactor previously described in (Ramaswamy et 
al., 2014; Salinas and Ramaswamy, 2014). We created a high density mesh of 
the fluid domain of the bioreactor as previously reported in (Salinas and 
Ramaswamy, 2014) with additional  4.5x104 tetrahedral elements in the sample 
region as seen in Figure 24 and imported it into the CFD solver.(CFX version, 
Ansys Inc., Canonsburg, PA). We replicated the simulations from (Salinas and 
Ramaswamy, 2014) where we analyzed cases of flow-alone, sample cyclic 
flexure-alone, flow and flexure, and a control group.   The inlet boundary 
condition was set to a velocity of 0.02 m/s for the cases of flex-flow and flow-
alone, and it was set to a velocity of zero for cases of cyclic flexure-alone and 
control. No slip conditions were prescribed to the bioreactor walls while a porous 
fluid-interface was set to the surface of the samples. All simulations were run 
utilizing a Newtonian, viscous model, with laminar flow conditions with the 
following fluid material properties: density = 1.01g/cm3 and dynamic viscosity = 
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1.27 cp which were previously measured for regular cell culture basal media 
(Ramaswamy et al., 2014). The outlet of the bioreactor was set to a zero relative-
pressure boundary condition. The housed bioreactor specimens were assumed 
to have a constant, homogeneous porosity that were saturated with cell culture 
medium.  The cell density prescribed was 17x106cells/cm2 (Engelmayr et al., 
2006). The rectangular sample dimensions (L X W X t) were as follows: 17mm x 
6.5 mm x 1mm equal to a total sample surface area of 2.68 cm2.  This 
represented a total number of cells of 4.556x107 in the surfaces on the 
rectangular samples. The results were analyzed after a convergence criteria of 
1x10-9 set for each of the momentum, continuity, mesh displacement, and mass 
transport equations were satisfied. Simulations were conducted in a Hewlett 
Packard work station with intel(R) Xeon(R) CPU, x5550@ 2.67GHz (2 
processors) with 16.0 GB installed memory and 64-bit windows 7 operating 
system.  
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Walls No slip conditions 
Inlet Plug velocity 0.02 m/s  
Outlet Outlet-Relative Pressure = 0 Pa 
Samples  Porous-fluid Interface 
Table 2.  Boundary conditions used for the CFD transport model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: a) Depiction of the entire fluid domain of the bioreactor chamber. Note 
the three scaffolds in a straight configuration and the plane (in red) at x = 
0.0175m corresponding to the longitudinal center line of the samples. b) Cross 
section (x =0.0175m) of the mesh. Note that the element density is higher inside 
the samples in order to better capture mass transport events. c) A close-up of the 
mesh around a single sample. 
 
 
  
a) 
b) 
c) 
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5.2   Convective-diffusive model 
Here, we built on this system by coupling the momentum transport 
(Salinas and Ramaswamy, 2014)  to a convective and diffusion mass transport 
model which can provide information on glucose and oxygen-species distribution 
within the housed bioreactor specimens over time and accounts for 
physiologically valid glucose and oxygen cell consumption rates.  The model is 
characterized by the following equations: 
   
   
  
 (    
        )       
    
  
(    ) 
    Mackie and Meares Relation            
 
         
   
       
  
 
   
     Michaelis-Menten Relation                                  
Where C β is the concentration of the solute in the medium;    is the fluid volume 
fraction;   is the sieving coefficient in a porous material; qβ is the source term for 
generation, consumption or degradation of solute mass; vf is the velocity of the 
fluid phase; Dβ is the effective diffusive coefficient in the porous medium; ρ cell is 
the density of cell seeded in the scaffold; V β is the maximum uptake rate,   
 
 is 
the concentration at half velocity. The diffusivity in the fluid was prescribed to be 
5.40x10-6 cm2/s for glucose and 5.40x10-6 cm2/s for oxygen (Das, 2007). 
Meanwhile, the diffusivity in the scaffold was set to be 1.08x10-6 cm2/s and 
0.60x10-5 cm2/s for glucose and oxygen respectively (Das, 2007). Finally, the 
glucose consumption rate was set to 3.83x10-16 mole/cell.s, while oxygen was 
assumed to be consumed at a rate of 3.75x10-17 mole/cell.s (Das, 2007).   
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Property Glucose Oxygen 
Diffusivity in Fluid cm2/s 5.40x10-6 3.00x10-5 
Diffusivity in scafffold cm2/s 1.08x10-6 0.60x10-5 
Metabolism rate in cell mole/cell.s 3.83x10-16 3.75x10-17 
Metabolism rate in cell grams/cell.s 6.90 x10-14 6.00x10-16 
Total Metabolism rate in sample g/s -3 x10-06 -2.7335 x10-08 
Table 3. Parameters used in the mass transport model. 
 
5.3 Porosity and Mass Fraction 
In order to determine the porosity of the PLA/PGA scaffold we first 
measured its dry mass (WS). Then, the scaffold was submerged in water. After 
that we recorded the weight of the water and the scaffold (WG). The weight of the 
residual water (WGl) was also recorded after the scaffold was removed from the 
container. 
The void volume was given by    
          
  
 and the total volume was 
    
         
  
. Where ρw is the density of water; the porosity of the sample 
was given by  
  
  
    . The porosity of the scaffold before any cell culture 
experiments was ~ 95%. After the cell culture experiments the scaffold showed a 
porosity of 75%. Glucose and Oxygen mass fractions in media were computed 
based on the glucose concentration in cell culture media (DMEM, fisher sci, 
pittbsurgh, PA) and from the ideal gas law respecitvely.  The mass fraction of 
glucose was found to be 0.0045, whereas for oxygen it was 0.00013.  
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5.4   Results 
As observed in Figures 25-29, the flow physics surrounding the 
engineered tissue constructs resembled those previously described in (Salinas 
and Ramaswamy, 2014). Briefly, flow was unidirectional during steady flow 
conditions acting on straight specimens and minor flow changes were observed 
on cases of steady flow and sample semi bent and fully bent configurations. Flow 
vortices were observed at the beginning of the bending cycle in cases of cyclic 
flexure-alone and they showed displacement and size changes at subsequent 
time steps. Similar events where observed during conditions of flow and sample 
flexure but with lower magnitude of events.  
 
 
 
 
 
 
 
 
 
 
Figure 25. Contour of velocity magnitudes and velocity streamlines in the plane 
(x= 17.5 mm) surrounding the specimens during flex-flow states 
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Figure 26. Contour of velocity magnitudes and velocity streamlines in the plane 
(x= 17.5 mm) surrounding the specimens during cyclic flexure-alone states. 
 
  
 
 
 
 
 
 
 
Figure 27.  Contour of velocity magnitudes and velocity streamlines in the plane 
(x= 17.5 mm) surrounding the specimens during steady flow-alone states. 
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Figure 28. Time averaged axial velocities (plane x = -0.0175 m)  from line at 
0.00015m below the inner wall. 
 
 
 
Figure 29. Time averaged axial velocities (plane x = -0.0175 m) from line at 
0.00015m above the outer wall. 
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Normalized mass fractions of glucose and oxygen were high at high 
porosities as seen in Figures 30-31. This is the norm for samples with porosity 
greater than forty percent. Approximately at forty percent porosity the mass 
fractions begin to decrease, and it is significantly lower at low sample porosities 
such as ten or five percent. There is no presence of mass fraction in samples 
that are fully solid (no porosity).  
At 75% porosity levels, there was no significant glucose mass fraction 
differences among cases of flex-flow, cyclic flexure-alone, flow-alone, and 
control. It can be observed in Figure 32 that the glucose mass fraction ranged 
from 0.967 to 0.991; analysis of variances shows no differences among groups at 
a significant level of p = 0.05.  The oxygen mass fraction ranged from 0.978 to 
0.999 as shown in Figure 33.  Analysis of variances shows no differences among 
groups at a significant level of p = 0.05.   
Normalized mass fraction contour along the center of the sample are 
shown in Figure 34. It can be seen that in the case of glucose, there is good 
uniformity in mass distribution along the center of the sample matrix. There is 
highest presence of glucose in the flex-flow case, followed by the cyclic flexure-
alone case. Next were the flow cases which showed very similar mass profiles 
among them.  The lowest presence of mass was seen in the control group. 
Similar scenarios were observed for the normalized mass transport of oxygen as 
seen in Figure 35.  
At sample porosities of 5%, there was significant glucose mass fraction 
differences among cases of flex-flow, cyclic flexure-alone, flow-alone, and 
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control. It can be observed in Figure 36 that the glucose mass fraction ranges 
from 0.144 to 0.002; analysis of variances revealed that all groups are different 
from each other at a significant level of p = 0.05 with the exception that the flow-
alone groups did not show significant differences among them.  The oxygen 
mass fraction ranges from 0.224 to 0.003 as seen in Figure 37.  Analysis of 
variances revealed that all groups are different from each other at a significant 
level of p = 0.05 with the exception that the flow-alone groups did not show 
significant differences among them.  
 
Figure 30. Time averaged normalized mass fraction for glucose at different 
porosity percentages. 
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Figure 31. Time averaged normalized mass fraction for oxygen at different 
porosity percentages. 
 
 
Figure 32. At 75% porosity: Area and time averaged normalized mass fraction at 
sample longitudinal wall at x = -0.0175m for glucose. 
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Figure 33. At 75% porosity: Area and time averaged normalized mass fraction at 
sample longitudinal wall at x = -0.0175m for oxygen. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. At 5% porosity: Time averaged normalized glucose mf (sample 
longitudinal wall at x = -0.0175m) for cases of flex-flow, cyclic flexure-alone, 
steady flow-alone and control.   
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Figure 35. Time averaged normalized oxygen mf (sample longitudinal wall at x = 
-0.0175m) for cases of flex-flow, cyclic flexure-alone, flow-alone and control.   
 
 
Figure 36. At 5% porosity: Area and time averaged normalized mass fraction at 
sample longitudinal wall at x = -0.0175m for glucose. 
0.144 0.086 0.057 0.057 0.056 0.002 
0.0
0.2
0.4
0.6
0.8
1.0
G
lu
c
o
s
e
 n
o
rm
a
liz
e
d
 m
f 
Glucose normalized mf 
Flex-flow 
Flow direction 
Steady flow-alone 
straight 
 
Control 
Steady flow-alone 
semi-bent 
 
Steady flow-alone 
fully-bent 
 
Cyclic flexure-alone 
 
Time averaged normalized 
oxygen mass fraction 
     0                 0.25                  0.5 
Center wall 
  
     0                 0.25                
0.5 
  
 
106 
 
 
Figure 37. At 5% porosity: Area and time averaged normalized mass fraction at 
sample longitudinal wall at x = -0.0175m for oxygen. 
 
ANOVA 
Normalized Glucose   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .001 5 .000 2.298 .110 
Within Groups .001 12 .000   
Total .002 17    
Table 4. At 75% porosity: Anova results for normalized glucose. 
 
ANOVA 
Normalized oxygen   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .001 5 .000 1.379 .299 
Within Groups .001 12 .000   
Total .002 17    
Table 5. At 75% porosity: Anova results for normalized glucose. 
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ANOVA 
Normalized glucose     
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .032 5 .006 642.116 .000 
Within Groups .000 12 .000   
Total .033 17    
Table 6. At 5% porosity: Anova results for normalized glucose. 
 
Multiple Comparisons 
Dependent Variable:   Normalized glucose       
Tukey HSD   
(I) Case (J) Case Mean 
Difference (I-J) 
Std. Error Sig. 
flex-flow 
Cyclic flexure-alone .0583826663
*
 .0025959427 .000 
steady flow-alone straight .0868963553
*
 .0025959427 .000 
steady flow-alone semi-bent .0870845327
*
 .0025959427 .000 
steady flow-alone fully-bent .0879335993
*
 .0025959427 .000 
control .1419857773
*
 .0025959427 .000 
Cyclic flexure-
alone 
flex-flow -.0583826663
*
 .0025959427 .000 
steady flow-alone straight .0285136890
*
 .0025959427 .000 
steady flow-alone semi-bent .0287018663
*
 .0025959427 .000 
steady flow-alone fully-bent .0295509330
*
 .0025959427 .000 
control .0836031110
*
 .0025959427 .000 
steady flow-alone 
straight 
flex-flow -.0868963553
*
 .0025959427 .000 
Cyclic flexure-alone -.0285136890
*
 .0025959427 .000 
steady flow-alone semi-bent .0001881773 .0025959427 1.000 
steady flow-alone fully-bent .0010372440 .0025959427 .998 
control .0550894220
*
 .0025959427 .000 
steady flow-alone 
semi-bent 
flex-flow -.0870845327
*
 .0025959427 .000 
Cyclic flexure-alone -.0287018663
*
 .0025959427 .000 
steady flow-alone straight -.0001881773 .0025959427 1.000 
steady flow-alone fully-bent .0008490667 .0025959427 .999 
control .0549012447
*
 .0025959427 .000 
steady flow-alone 
fully-bent 
flex-flow -.0879335993
*
 .0025959427 .000 
Cyclic flexure-alone -.0295509330
*
 .0025959427 .000 
steady flow-alone straight -.0010372440 .0025959427 .998 
steady flow-alone semi-bent -.0008490667 .0025959427 .999 
control .0540521780
*
 .0025959427 .000 
control 
flex-flow -.1419857773
*
 .0025959427 .000 
Cyclic flexure-alone -.0836031110
*
 .0025959427 .000 
steady flow-alone straight -.0550894220
*
 .0025959427 .000 
steady flow-alone semi-bent -.0549012447
*
 .0025959427 .000 
steady flow-alone fully-bent -.0540521780
*
 .0025959427 .000 
Table 7. At 5% porosity: Multiple comparisons using Tukey’s test for normalized 
glucose. 
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ANOVA 
Normalized oxygen   
 Sum of 
Squares 
df Mean Square F Sig. 
Between Groups .082 5 .016 55.448 .000 
Within Groups .004 12 .000   
Total .085 17    
Table 8. At 5% porosity: Anova results for normalized oxygen. 
 
Multiple Comparisons 
Dependent Variable:   Normalized oxygen     
Tukey HSD   
(I) Case (J) Case Mean 
Difference (I-
J) 
Std. Error Sig. 
flex-flow 
Cyclic flexure-alone .1000000000
*
 .0140037338 .000 
steady flow-alone  straight .1494511033
*
 .0140037338 .000 
steady flow-alone semi-bent .1494511033
*
 .0140037338 .000 
steady flow –alone fully-bent .1494511033
*
 .0140037338 .000 
control .2209281770
*
 .0140037338 .000 
Cyclic flexure-
alone 
flex-flow -.1000000000
*
 .0140037338 .000 
steady flow-alone straight .0494511033
*
 .0140037338 .037 
steady flow-alone semi-bent .0494511033
*
 .0140037338 .037 
steady flow-alone fully-bent .0494511033
*
 .0140037338 .037 
control .1209281770
*
 .0140037338 .000 
steady flow-alone  
straight 
flex-flow -.1494511033
*
 .0140037338 .000 
Cyclic flexure-alone -.0494511033
*
 .0140037338 .037 
steady flow-alone semi-bent .0000000000 .0140037338 1.000 
steady flow-alone  fully-bent .0000000000 .0140037338 1.000 
control .0714770737
*
 .0140037338 .003 
steady flow-alone  
semi-bent 
flex-flow -.1494511033
*
 .0140037338 .000 
Cyclic flexure-alone -.0494511033
*
 .0140037338 .037 
steady flow –alone straight .0000000000 .0140037338 1.000 
steady flow-alone fully-bent .0000000000 .0140037338 1.000 
control .0714770737
*
 .0140037338 .003 
steady flow –alone flex-flow -.1494511033
*
 .0140037338 .000 
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fully-bent Cyclic flexure-alone -.0494511033
*
 .0140037338 .037 
steady flow-alone straight .0000000000 .0140037338 1.000 
steady flow-alone semi-bent .0000000000 .0140037338 1.000 
control .0714770737
*
 .0140037338 .003 
control 
flex-flow -.2209281770
*
 .0140037338 .000 
Cyclic flexure-alone -.1209281770
*
 .0140037338 .000 
steady flow –alone straight -.0714770737
*
 .0140037338 .003 
steady flow-alone  semi-bent -.0714770737
*
 .0140037338 .003 
steady flow-alone fully-bent -.0714770737
*
 .0140037338 .003 
 
Table 9. At 5% porosity: Multiple comparisons using Tukey’s test for normalized 
oxygen. 
 
 
5.5 Discussion 
Previously, we computationally investigated the effects of sample 
movement on the flow physics surrounding tissue engineered constructs (Salinas 
and Ramaswamy, 2014). We virtually replicated the experimental set up of a 
particularly relevant in vitro heart valve tissue engineering experiment conducted 
by Engelmayr et al. (Engelmayr et al., 2006) where rectangular PLA/PGA non-
woven, fibrous scaffolds seeded with BMSCs where mechanically conditioned in 
a FSF bioreactor. They showed that cyclic specimen flexure combined with a 
steady flow source greatly augmented engineered collagen production when 
compared to cases of cyclic flexure-alone or steady flow-alone. Our previous 
computational findings (Salinas and Ramaswamy, 2014)  led us to note that a 
combination of shear stress magnitude and oscillatory shear stress directly 
correlated with collagen augmentation while each parameter on its own could not 
explain greater tissue formation. In addition, sample flexure may have enhanced 
nutrient delivery of glucose and oxygen through the walls of engineered 
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constructs and into the cells and tissues thereby adding in the process of tissue 
production.    
In this study, we sought to computationally determine if, in addition to OSI-
   ⃗⃗ ⃗⃗   (Salinas and Ramaswamy, 2014), mass transport of glucose and oxygen 
played a role in augmented tissue formation reported in the in vitro flex-flow case 
(Engelmayr et al., 2006).  We incorporated a convective-diffusive mass transport 
model  (Das, 2007; Sengers et al., 2005) to our previously validated CFD 
simulations where we looked at cases of flex-flow, cyclic flexure-alone, flow-
alone and controls. We elected this mass transport model because it provided 
with mass concentration of glucose and oxygen species resulting from 
convective and diffusive activity over time anywhere in the bioreactor and it used 
physiologically valid cell consumption rates of both species.  
Tissue culture and mathematical based studies have clearly established 
the importance of adequate oxygen (Kumar et al., 2004; Wang et al., 2008) and 
glucose delivery (Boubriak et al., 2006; Converti et al., 1996; Mokhbi Soukane et 
al., 2007) for adequate cell activity and tissue formation and noted that any 
unmet demand of nutrients can lead to low cell proliferation, and low collagen 
production particularly at the center of scaffolds with low porosities (Ishaug-Riley 
et al., 1998; Patnaik et al., 2013).  
Some studies have reported that scaffolds used for tissue engineering 
experiments have porosity as low as 73% (Yu et al., 2009) after cell and tissue 
culture. During an in-house in vitro experiment, we determined that the porosity 
of the 50:50 PLA/PGA scaffold was 95% before culture and 75 % porous after 
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tissue culture experiments. Our simulations showed that there is adequate 
delivery of both glucose and oxygen at high specimen porosities ranging from 
forty percent porosity and higher (Figure 30-31). We confirmed this observation 
by performing an anova test which showed no difference in the mass fraction of 
glucose and oxygen during cases of flow, flexure and both combined. These 
results suggest that sample cyclic flexure does not enhance nutrient delivery to 
the center of engineered tissue constructs because diffusivity effects dominate 
when scaffolds have high porosities, which is usually the norm for tissue 
engineering studies that started tissue culture experiments with a highly porous 
specimen (Yu et al., 2009). We note however that at low sample porosities (5%), 
our simulations do show that sample movement enhanced nutrient delivery as 
shown in figures 34-37 and validated by an anova study (Table 8-9). Although 
low porosities are unlikely to be seen in tissue engineering studies, we 
acknowledge that in some cases such as using decellularized scaffolds with high 
ECM content low porosities can be observed and sample movement should be 
highly considered in order to enhance nutrient transport. In addition, studies 
using scaffolds with high thickness such as whole organ development may also 
benefit from scaffold bending modes.  
 
CHAPTER 6: PRELIMINARY EXPERIMENTAL OBSERVATIONS FOR OSI-   ⃗⃗ ⃗⃗   
6.1 Introduction  
 We have computationally shown by an initial approximation given as OSI-
   ⃗⃗ ⃗⃗  that both OSI and TSSM combined correlated with significantly higher 
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engineered collagen production during modes of sample cyclic flexure combined 
with a steady flow source. The OSI-   ⃗⃗ ⃗⃗  was defined as twice the product of the 
TSSM and the OSI. In previously resolved simulations (Salinas et al., 2014a; 
Salinas et al., 2014b), we noted that oscillatory shear environments can be 
maximized by a pulsatile flow source passing by straight static specimens. We 
believe that the OSI-   ⃗⃗ ⃗⃗  parameter is also present in significant magnitude when 
flat specimens are subjected to physiologically valid pulsatile flow conditions and 
that OSI-   ⃗⃗ ⃗⃗  is responsible for inducing higher cell proliferation, gene expression 
and tissue formation. In this study, we performed 2D in vitro cell culture 
experiments where we subjected BMSCs seeded in straight surfaces to 
conditions of physiologically valid pulsatile flow conditions and steady state flow 
conditions. We conducted cell proliferation and gene expression assays and 
determined if pulsatility environments enhanced these traits. In addition, we 
performed a CFD simulation that replicated this in vitro experiment in order to 
delineate and quantify OSI, TSSM, and OSI-   ⃗⃗ ⃗⃗  parameters. Finally, we wanted 
to correlate these parameters with results from the cell proliferation and gene 
expression assays.  
6.2 Methodology for Cell Culture experiments 
6.2.1 Cell Differentiation: BMSCs were cultivated in T-75 flasks in a 37oC 
incubator until 100% confluence was obtained, and were subsequently divided to 
obtain a cell density of 17x106 cells/cm2 and cultured for an additional week. The 
no flow (control) group  (n=4) was cultured in the Bioflux 200 system (Fluxion 
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Biosciences, San Francisco, CA) system without any flow sources.  The steady 
flow group (n=4) was cultured in the Bioflux 200 system and exposed to a steady 
flow source capable of inducing an averaged shear stress of 1.5dyn/cm2. The 
pulsatile flow group was cultured in the Bioflux 200 system and exposed to a 
pulsatile shear stress obtained from a physiological pulmonary artery waveform 
(Lotz et al., 2002).  
6.2.2 Culture Media: The culture media contained DMEM High glucose 
(Invitrogen, Carlsbald, CA), 10% fetal bovine serum (ATCC, Manasas, VA), 1% 
antibiotic/antimycotic, 1% HEPES (Invitrogen, Carlsbald, CA), 2ηg/mL of basic 
fibroblast growth factor (bFGF, Invitrogen, Carlsbald, CA), 82µg/mL Ascorbic 
Acid (Sigma-Aldrich, St. Louis, MO). Media changes were performed every 24 
hours for a period of one week. The amount of media added to each well for the 
24-microfluidic well plate in the bioflux system was 3ml for the 96-well plate was 
200µL for the controlgroup.  The media contained 82µg/mL of Ascorbic acid. 
6.2.3 Bioflux 200 System: The Bioflux 200 system comprises of a pneumatic 
pump, a 24-microfluidic well plate, a 24-well plate interface, and a user operated 
software. It permits mechanical conditioning of rectangular channels seeded with 
cells by inducing steady or pulsatile flow conditions   The Bioflux 200 is 
connected to a microscope with a CCD camera allowing the user to take 
photographs of the cultured cells under flow.  This system is efficient for stem cell 
applications, such as cell differentiation and gene expression. 
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6.2.4 Assays:  
Cell Differentiation-RNA Isolation and Reverse Transcription: SMCs were 
washed with PBS and detached from the T-75cm2 flask (Fisher Scientific, PA) by 
0.25%Trypsin-EDTA (ATCC, Manasas, VA). Then, the detached cells were 
collected in a 15 ml conical tube (Fisher Scientific, PA). For the RNA isolation 
procedure, the cells were transferred to a 1.5 ml RNAase free tube. Purification 
of mRNA was performed through the SV Total RNA Isolation System (Promega, 
Madison, WI). We conducted Reverse transcription reaction on 1µg of total 
mRNA with GoScript™ Reverse Transcription System (Promega, Madison, WI). 
The detection process was achieved through a Step One Real-Time PCR 
System (Applied Biosystems, Carlsbad, CA). The cycling parameters were 950C, 
5 seconds; 600C, 45 seconds; 950C, 15 seconds. 
6.2.5 CFD Simulations  
Using Ansys™ commercial software (Ansys Inc, Canonsburg, PA), the fluid 
domain of the rectangular bioflux channel was constructed. The structured 
mesh was composed of one million elements. Physical properties for bioreactor 
media were used with density = 1.01 g cm3 and dynamic Viscosity = 1.27 
centipoise. At the inlet, a physiologically valid velocity waveform (Lotz et al., 
2002) was imposed (Figure 38). The outlet was set to 0 relative pressure and all 
walls were set to no-slip conditions. Simulations were run in a Hewlett 
Packard™ work station with  intel(R)  Xeon(R) CPU, x5550@ 2.67GHz 
(2processors) with 16.0 GB installed memory and 64-bit windows 7 operating 
system. Independence tests were performed on mesh, time step, and 
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periodicity for steady and pulsatile simulations accordingly. We monitored the 
area averaged wall shear stress on the surface, and a 5% error acceptance 
criterion in comparison with highly resolved simulations was used. All 
simulations converged to 10-9. We computed oscillations in the flow by using the 
OSI parameter described by He and Ku (He and Ku, 1996) and the OSI-   ⃗⃗ ⃗⃗   
parameter as described by (Salinas and Ramaswamy, 2014). 
 
 
Figure 38. Velocity waveform with a velocity average of 0.199386 cm/s. It was 
used as the inlet velocity for the transient pulsatile simulations at 2 millisecond 
intervals.  
 
6.2.6 Statistics 
We performed analysis of variance tests in order to determine if the significant 
differences between control, steady flow and pulsatile flow groups. We used 
Tukey’s test with a significance of p = 0.05. Normality distributions and equal 
variance were assumed.   
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6.3 Results 
6.3.1 In vitro Experiments 
 In Figures 39-56 it we showed a section of the channel where the cells are 
attached to the walls. During cell seeding, the shape of the cells was mainly 
rounded and began to elongate in the following days.  In the case of the steady 
flow, cells showed a slight formation in the flow axial direction. This event was 
also seen in the pulsatile flow group, but with less intensity than the steady flow 
case. Both steady and pulsatile groups showed higher number of cells attached 
to the walls when compared to the control group.  Cells counts for each group 
were conducted and reported in Figure 57. Indeed, we observed that there were 
more cells in the pulsatile flow group followed by the steady flow case, and the 
control group, respectively. We performed an anova study which determined that 
there are significant differences between the means of these groups as shown in 
Table 10. At a significance of p = 0.05, Tukey’s test revealed that there are no 
significant differences between the three groups when compared to each other 
seen in table 11.    
 
 
Figure 39. Control group. Cell attached to the walls of the bioflux 200 system day 
1. 
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Figure 40. Control group. Cell attached to the walls of the bioflux 200 system day 
5. 
 
 
 
Figure 41. Control group. Cell attached to the walls of the bioflux 200 system day 
6. 
 
 
 
Figure 42. Control group. Cell attached to the walls of the bioflux 200 system day 
7. 
 
  
 
118 
 
 
 
Figure 43. Steady flow group. Cell attached to the walls of the bioflux 200 system 
day 1. 
 
 
 
Figure 44. Steady flow group. Cell attached to the walls of the bioflux 200 system 
day 2. 
 
 
 
 
Figure 45. Steady flow group. Cell attached to the walls of the bioflux 200 system 
day 3. 
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Figure 46. Steady flow group. Cell attached to the walls of the bioflux 200 system 
day 4. 
 
 
 
Figure 47. Steady flow group. Cell attached to the walls of the bioflux 200 system 
day 5. 
 
 
 
Figure 48 Steady flow group. Cell attached to the walls of the bioflux 200 system 
day 6. 
 
  
 
120 
 
 
 
Figure 49. Steady flow group. Cell attached to the walls of the bioflux 200 system 
day 7. 
 
 
 
Figure 50. Pulsatile flow group. Cell attached to the walls of the bioflux 200 
system day 1. 
 
 
 
 
Figure 51. Pulsatile flow group. Cell attached to the walls of the bioflux 200 
system day 2. 
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Figure 52. Pulsatile flow group. Cell attached to the walls of the bioflux 200 
system day 3. 
 
 
 
Figure 53. Pulsatile flow group. Cell attached to the walls of the bioflux 200 
system day 4. 
 
 
 
Figure 54. Pulsatile flow group. Cell attached to the walls of the bioflux 200 
system day 5. 
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Figure 55. Pulsatile flow group. Cell attached to the walls of the bioflux 200 
system day 6. 
 
 
 
Figure 56. Pulsatile flow group. Cell attached to the walls of the bioflux 200 
system day 7. 
 
 
Figure 57. Bar chart showing the number of cells during control, steady, and 
pusatile  flow experiments. 
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ANOVA 
Cell Count   
 Sum of Squares df Mean Square F Sig. 
Between Groups 656472616.667 2 328236308.333 44.188 .000 
Within Groups 66853725.000 9 7428191.667   
Total 723326341.667 11    
Table 10. Anova results for cell count from control, steady and pulsatile flow 
conditions 
 
Multiple Comparisons 
Dependent Variable:   Cell Count   
Tukey HSD   
(I) Flow (J) Flow Mean Difference 
(I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper 
Bound 
No flow 
Steady flow -5457.50000
*
 1927.19896 .047 -10838.2503 -76.7497 
Pulsatile flow -17690.00000
*
 1927.19896 .000 -23070.7503 -12309.2497 
Steady flow 
No flow 5457.50000
*
 1927.19896 .047 76.7497 10838.2503 
Pulsatile flow -12232.50000
*
 1927.19896 .000 -17613.2503 -6851.7497 
Pulsatile flow 
No flow 17690.00000
*
 1927.19896 .000 12309.2497 23070.7503 
Steady flow 12232.50000
*
 1927.19896 .000 6851.7497 17613.2503 
Table 11. Post hoc tests. Multiple comparisons using Tukey’s test for cell counts 
from control, steady and pulsatile flow conditions. 
 
 Figures 58-60 indicate gene expression of BMSCs when exposed to 
control, steady flow and pulsatile flow environments, respectively. The graph was 
normalized to GAPDH. In the control group   there was strong expression of 
GAPDH and B-integrin genes. Also, there was weak expression of PECAN-1 and 
VE-Cadherin genes.  In the steady flow group   there was strong expression of 
GAPDH and B-integrin PECAN-1 and VE-Cadherin genes. In the pulsatile flow 
group   there was strong expression of GAPDH and B-integrin, Thy-1, and Tie-1 
genes.  Also, there was weak expression of PECAN-1, VE-Cadherin, and FLK-1 
genes.  
  Previously computed OSI contours (Rath et al., 2014) are shown in figure 
61a. In can be seen that there was high oscillatory shear environments acting on 
the walls of the channels seeded with BMSCs. The area averaged OSI was 0.49. 
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In this study we also reported on the TSSM that the walls were exposed to, and it 
is shown in Figure 61b. The area averaged TSSM was 197 Pa. Finally, we 
computed the OSI-   ⃗⃗ ⃗⃗ , shown in Figure 61c. The area averaged OSI-   ⃗⃗ ⃗⃗  was 195 
Pa.   Due to the high OSI values, the OSI-   ⃗⃗ ⃗⃗  values approximate to the time 
averaged shear stresses per our definition of OSI-   ⃗⃗ ⃗⃗  (Salinas and Ramaswamy, 
2014), which was our original intent when defining it in this manner. 
 
Figure 58. Genes expressed after control conditions.  
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Figure 59. Genes expressed after steady flow conditions.  
 
 
Figure 60. Genes expressed after pulsatile flow conditions.  
 
 
0.00001
0.001
0.1
10
G
A
P
D
H
B
-i
n
t
P
E
C
A
N
-1
V
E
_
C
A
D
T
H
Y
-1
F
L
K
-1
T
IE
-1
Genes expressed after steady flow conditions 
0.00001
0.001
0.1
10
G
A
P
D
H
B
-i
n
t
P
E
C
A
N
-1
V
E
_
C
A
D
T
H
Y
-1
F
L
K
-1
T
IE
-1
Genes expressed after pulsatile flow conditions 
  
 
126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 61. Contours of a) OSI (Rath et al., 2014) , b) Time averaged shear 
stress, and c) OSI-   ⃗⃗ ⃗⃗   of the bioflux 200 rectangular channel seeded with BMSCs.  
 
6.4 Discussion  
 OSI-   ⃗⃗ ⃗⃗  computationally obtained by (Salinas and Ramaswamy, 2014) has 
been linked to promote engineered collagen formation by BMSCs in vitro heart 
valve tissue engineering experiments (Engelmayr et al., 2006).  However, OSI-   ⃗⃗ ⃗⃗  
has not been associated to increase BMSCs proliferation or gene expression. In 
this study we decided to conduct a preliminary in vitro experiment where BMSCs 
where exposed to cell culture environments where OSI-   ⃗⃗ ⃗⃗  can be maximized 
within physiologically valid ranges. Previously, we reported that oscillatory shear 
environments can be maximized by using a physiologically derived pulsatile flow 
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source acing on straight static specimens (Salinas et al., 2014a; Salinas et al., 
2014b). We noted that this set up should also have high OSI-   ⃗⃗ ⃗⃗  values, which 
encouraged us to seed BMSCs in perfectly flat rectangular cell culture channels 
in a bioflux200 system (Fluxion Biosciences, San Francisco, CA) and expose 
them to pulsatile flow.  
 We computationally simulated the experimental set up in Ansys CFX 
(Ansys, Canonsburg, PA) and found that indeed OSI-   ⃗⃗ ⃗⃗  strongly acted on the 
surfaces of the BMSCs seeded channels as seen in Figure 60c. Given the high 
degree of oscillations in the wall shear direction (Figure 61a), the OSI-   ⃗⃗ ⃗⃗  closely 
resembled the TSSM values (Figure 61b). We note that in the control and steady 
flow cases, there was no presence of OSI-   ⃗⃗ ⃗⃗  values given that they are not time 
dependent scenarios. OSI-   ⃗⃗ ⃗⃗  was only present in the pulsatile case.  There was 
significantly (p<0.05) higher number of cells in the pulsatile case when compared 
to the control and steady flow cases (Table 11). In addition, there was significant 
(p>0.05) differences between the control and steady group. This finding suggests 
that while shear stress along does mildly influence cell proliferation when acting 
alone, when accompanied by oscillatory shear environments there is enhanced 
BMSCs proliferation.  
We considered genetic markers for smooth muscle cells (SMCs) 
particularly integrin, beta1, THY-1, FZD2, and MLC1F. We also studied 
endothelial cell (ECs) genes comprising PECAN-1, FLK1, and VE-cadherin. 
Gene expression assays revealed that all groups had strong presence of GAPDH 
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B-int, PECAN1, and VE-cadherin genes with the exception that the control group 
showed weak presence of Pecan-1 and VE-cadherin as seen in Figure 58-60.  In 
addition, the pulsatile case group showed strong presence of Thy-1 and Tie-1 
genes and significant presence of Flk-1 gene when compared to control and 
steady groups which did not account for these genes. In brief, B-int (integrin 
beta1) is involved in cell adhesion, tissue repair, and embryogenesis; THY-1 
regulates adhesion, migration, and fibrosis cell- cell, and cell–matrix interactions. 
PECAM1 participates in leukocyte migration, angiogenesis, and integrin 
activation. FLK1 is a signaling protein for vascular endothelial growth factor; TIE1 
regulates cell adhesion molecules. Lastly, VE-cadherin participates in 
angiogenesis (Martinez et al., 2013). 
 Importantly, Thy-1 has been shown to be present in undifferentiated stem 
cells (Martinez et al., 2013). Thus as a preliminary experimental finding, we have 
found here through increased Thy-1 expression from oscillatory flow conditions, 
that BMSCs remain in a less differentiated state. This has important implications 
from a heart valve tissue engineering stand point as a TEHV could benefit from 
the plasticity of cell lineages during in vitro studies using heart valve like 
geometries or after in vivo implantation.  Further studies to confirm BMSC-based 
gene expression outcomes under different flow states are ongoing by other 
investigators in our laboratories.  
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CHAPTER 7: CONCLUSIONS, LIMITATIONS, FUTURE WORK 
 In this study we developed moving boundary CFD simulations to study the 
effects of movement of engineered tissue constructs on the flow physics and 
mass transport. In addition, we correlated the computational results with 
engineered collagen formation, cell proliferation and cell phenotype from 
literature and in-house in vitro experiments. We presented a modification of the 
traditional OSI parameter (He and Ku, J. Biomech Eng., 1996)  given by: OSI-   ⃗⃗ ⃗⃗  
= 2 * OSI * ∫    ( )  
 
 
  and demonstrated that the OSI-   ⃗⃗ ⃗⃗  correlated strongly 
with the greatly augmented engineered collagen production reported from 
previous in vitro experiments (Engelmayr et al., 2006), under flex-flow 
conditioning regimens.   
We presented a convective-diffusive mass transport model to study sample 
movement effects on mass transport of glucose and oxygen. We found that 
sample flexure of 75% porous scaffolds did not enhance mass transport of 
glucose and oxygen, but sample flexure of 5% porous scaffolds did enhance 
mass transport of glucose and oxygen. We noted that in tissue engineered 
studies, sample porosity ranges from 92-0.73% porosity (Yu et al. Int J. Heat 
&Mass transfer, 2009). This suggests that mass transport did not enhance tissue 
production reported in (Engelmayr et al., 2006). We reported that mass transport 
of glucose and oxygen is independent of specimen shape as seen by the flow-
alone cases with straight, semi-bent and fully bent sample geometries. We note 
that in this particular study, the initial definition of OSI-   ⃗⃗ ⃗⃗ (Salinas and 
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Ramaswamy, J. Biomech, 2014) was the only fluid induced parameter that 
correlated with augmented tissue formation by BMSCs. We computationally 
showed that OSI-   ⃗⃗ ⃗⃗  environments can be maximized during conditions of high 
oscillatory shear caused by physiologically valid pulsatile flow conditions (Figure 
61). In an effort to observe to effect of OSI-   ⃗⃗ ⃗⃗  on cell proliferation and cell 
phenotype, we conducted an in vitro experiment where BMSCs implanted on cell 
culture channels in a bioflux200  where exposed physiologically valid pulsatile 
conditions. We showed that OSI-   ⃗⃗ ⃗⃗  environments up-regulated cell differentiation 
and cell phenotype. We thus recommend that heart valve tissue engineering 
protocols utilize physiologically valid pulsatile flow sources to mechanically 
condition, by means of OSI-   ⃗⃗ ⃗⃗  environments, BMSCs implanted in rectangular 
cell/tissue culture environments as it has been shown to play a significant role in 
tissue formation, cell proliferation and cell phenotype.  
In this study, our mass transport model considered only two species: 
glucose and oxygen. In addition, it only considered diffusivity effects in cell 
culture media and scaffold matrix. Furthermore we did not consider any stretch 
modes. Stretching of engineered tissue constructs may mediate BMSCs activity. 
Our in vitro study was conducted in a 2-D set up and did not account for collagen 
formation.   
 Future studies in our laboratories will be aimed at addressing the main 
limitations described above. The mass transport model will be modified in order 
to include cell specific permeability and account for more species including for 
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example lactate and important growth factors. The 3-D in-house cell and tissue 
culture studies will be performed using an FSF bioreactor containing BMSCs 
seeded porous scaffolds fixed in a straight configuration. A physiologically valid 
pulsatile flow source will be used to mechanically condition the engineered 
constructs and the results of BMSC gene expression will be correlated to shear 
stress and shear stress variants (e.g. OSI and OSI-   ⃗⃗ ⃗⃗ ).    
 As an initial effort, we have conducted the CFD simulations based on a 
square pulsatile velocity waveform (Figure 62) that yielded 850 ml/min flow rate 
used in similar bioreactor studies (Ramaswamy et al., 2014). We calculated the 
TSSM, OSI and OSI-   ⃗⃗ ⃗⃗  values for the three rectangular specimens, which are 
shown in Figure 63. The area averaged values for the inner wall (n=3) were 0.15 
± 0.011 Pa, 0.45 ± 0.023, 0.14 ±0.015 Pa for TSSM, OSI and OSI-   ⃗⃗ ⃗⃗  , 
respectively.  In the case of the outer wall, the area averaged values were 0.12 ± 
0.012 Pa, 0.29 ± 0.019, 0.073 ± 0.002 Pa for TSSM, OSI and OSI-   ⃗⃗ ⃗⃗  , 
respectively. Clearly, these CFD results (Figure 63a) show that relatively large 
magnitudes of OSI-   ⃗⃗ ⃗⃗  can be created through flow pulsatility on fixed, nonmoving 
specimens.  In other words, any effect by specimen movement to improve 
engineered tissue formation and gene expression outcomes from BMSCs, via 
altered mass transport mechanisms will be eliminated.  Future bioreactor 
experiments in our laboratories, in-line with these CFD simulations will delineate 
if OSI-   ⃗⃗ ⃗⃗  is the sole regulator of enhanced BMSCs gene expression and tissue 
formation in the context of the heart valve phenotype. 
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Figure 62. Idealized velocity waveform.  
 
Figure 63. Contours of the inner and outer walls of the fixed rectangular 
specimens for a) TSSM; b) OSI; c) osi-   ⃗⃗  ⃗. 
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